Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.778341374052225e-39,28.973415132924334,2563.3224676394475,"['RPL4', 'RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS6KA6', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS6KB1', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.1234278522173504e-36,0,0,77
2,Oxidative phosphorylation WP623,9.341067639391863e-10,5.912300540268878,122.92518504467026,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV2', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFS1']",2.6248400066691135e-07,0,0,32
3,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.6442695930158596e-08,3.4903445664521016,62.55878761385201,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'COX17', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'UQCR11', 'UQCR10', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1A', 'ATP5F1B', 'NDUFV2', 'NDUFV1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS1', 'SLC25A5', 'SLC25A4', 'SLC25A6']",3.0802650375830438e-06,0,0,44
4,Nonalcoholic fatty liver disease WP4396,9.581412267238126e-06,2.3110373181530677,26.70562056266177,"['NDUFA13', 'COX7B', 'NDUFA11', 'PRKAG1', 'COX7C', 'AKT3', 'LEPR', 'RAC1', 'MAP3K5', 'NDUFC2', 'NDUFC1', 'PRKAB1', 'COX6B1', 'PIK3CA', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS1', 'PPARA', 'ATF4', 'NDUFB9', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB2', 'NDUFB1', 'UQCR11', 'UQCR10', 'ADIPOR1', 'COX7A1', 'UQCRH', 'CDC42', 'NDUFV2', 'NDUFV1', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'COX6C', 'NFKB1', 'CYCS', 'BAX', 'MAP3K11']",0.0013461884235469567,0,0,50
5,Proximal tubule transport WP4917,0.0002931588695784482,4.133426966292135,33.624584651137454,"['ATP6V1A', 'ATP6V1G1', 'ATP6V0B', 'ABCB1', 'SLC20A2', 'SLC1A1', 'SLC3A1', 'SLC3A2', 'ATP1A1', 'ATP1B1', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1C1', 'ATP6V1F']",0.030940025900814846,0,0,15
6,Photodynamic therapy-induced unfolded protein response WP3613,0.0003303205612186638,4.774451097804391,38.26935962051043,"['PPP1R15A', 'XBP1', 'WARS', 'HSPA5', 'UBE2E1', 'PDIA6', 'HSP90B1', 'NARS', 'DDIT3', 'DNAJB9', 'CALR', 'EIF2A', 'ATF4']",0.030940025900814846,0,0,13
7,Mitochondrial complex I assembly model OXPHOS system WP4324,0.0006878795156474924,2.6968748696123837,19.638364639374263,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFS1', 'NDUFV2', 'NDUFV1']",0.05522689825627011,0,0,22
8,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.00280485999067081,2.5875678583655306,15.205588046495109,"['PPP1R15A', 'PPP1R16B', 'PPP1R14A', 'PPP1R14B', 'XBP1', 'PPP1R13B', 'PPP1R12A', 'HSPA5', 'PPP1R10', 'EIF2AK2', 'PPP1R9A', 'PPP1R2', 'PPP1R3F', 'MAP1LC3A', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'ATF4']",0.18594458537727904,0,0,18
9,Proteasome Degradation WP183,0.0031780237243701722,2.274197333834022,13.080036290443724,"['UBE2B', 'H2AFZ', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F', 'PSMA7', 'PSMD8', 'PSMA5', 'PSMB6', 'PSMB7', 'PSMA3', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC6', 'PSMB2', 'PSMA2', 'PSMD2', 'PSME3', 'PSMC1', 'PSME2']",0.18594458537727904,0,0,22
10,Cellular Proteostasis WP4918,0.003308622515609947,16.492537313432837,94.1925639518509,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5']",0.18594458537727904,0,0,5
11,Myometrial relaxation and contraction pathways WP289,0.006175118253359062,1.7259371941619506,8.780234719560358,"['ATF1', 'RYR1', 'RYR2', 'CAMK2D', 'YWHAB', 'RGS16', 'ITPR1', 'ITPR2', 'ATP2A2', 'ADCY2', 'ADCY8', 'SLC8A1', 'ACTG1', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'JUN', 'GSTO1', 'IGFBP3', 'PRKCE', 'PDE4D', 'PRKCA', 'NFKB1', 'CREB3', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'GNB1', 'CRH', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1', 'ATF4']",0.3111480976298906,0,0,37
12,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.009350680520054482,8.245335820895523,38.52473330961172,"['GALNT3', 'SPP1', 'FAM20C', 'NFKB1', 'FGFR2']",0.3111480976298906,0,0,5
13,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.009350680520054482,8.245335820895523,38.52473330961172,"['MEF2A', 'CAMK2D', 'MEF2C', 'CCND2', 'MEF2D']",0.3111480976298906,0,0,5
14,Airway smooth muscle cell contraction WP4962,0.009499574119085915,4.619268110530246,21.509660347192337,"['RYR1', 'PPP1R14A', 'ROCK1', 'GNAQ', 'PLCB1', 'CALM1', 'MYLK']",0.3111480976298906,0,0,7
15,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.011161699997163214,3.7713858797161,16.953386504948508,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF2S2', 'EIF3D', 'EIF1']",0.3111480976298906,0,0,8
16,Synaptic Vesicle Pathway WP2267,0.011736785820060058,2.12429696287964,9.442557955707503,"['UNC13C', 'RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTC', 'CLTA', 'SYP', 'AP2B1', 'SYN3', 'SYN2', 'DNM2', 'CPLX3', 'DNM3', 'SLC17A7', 'STX3', 'SLC25A4', 'AP2M1']",0.3111480976298906,0,0,18
17,Translation Factors WP107,0.011736785820060058,2.12429696287964,9.442557955707503,"['EIF4A2', 'EIF4A1', 'EIF1AX', 'EIF2AK2', 'EIF2S2', 'EIF1', 'EEF1B2', 'EEF1G', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF3D', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.3111480976298906,0,0,18
18,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.012091623348291551,3.3004484304932737,14.572279688875062,"['EGLN1', 'LDHA', 'PDHA1', 'RPS6', 'PRKAG1', 'PDHB', 'PRKAB1', 'ACACB', 'ACACA']",0.3111480976298906,0,0,9
19,Glycolysis and Gluconeogenesis WP534,0.012314886196838508,2.641526374859708,11.614650118146487,"['LDHA', 'PDHA1', 'PKM', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'GOT2', 'SLC2A3', 'ALDOC', 'PFKM', 'PFKP']",0.3111480976298906,0,0,12
20,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.012530539549911039,2.7935101547666994,12.234419222742302,"['ATF1', 'CREB3', 'CAMK2D', 'CAMK1D', 'GNAQ', 'ITPR1', 'ITPR2', 'CALM3', 'CALM1', 'CREB5', 'ATF4']",0.3111480976298906,0,0,11
21,miR-517 relationship with ARCN1 and USP1 WP3596,0.012630505072718344,inf,inf,"['ID2', 'USP1', 'ARCN1']",0.3111480976298906,0,0,3
22,Exercise-induced Circadian Regulation WP410,0.01351841102040817,2.202322967403522,9.478143396558579,"['NCKAP1', 'IDI1', 'DAZAP2', 'GSTM3', 'CEBPB', 'BTG1', 'QKI', 'HERPUD1', 'DNAJA1', 'PER1', 'SUMO1', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.3111480976298906,0,0,16
23,Regulation of Microtubule Cytoskeleton WP2038,0.01351841102040817,2.202322967403522,9.478143396558579,"['TRIO', 'ROCK1', 'PRKCA', 'CDC42', 'TIAM1', 'PIK3CA', 'CFL2', 'DPYSL2', 'TAOK1', 'GNAQ', 'ABL1', 'RAC1', 'MAPT', 'PRKACA', 'CLASP1', 'MARK1']",0.3111480976298906,0,0,16
24,Fragile X Syndrome  WP4549,0.013595726726338962,1.611469430752107,6.926095205531316,"['CYFIP2', 'GRIA1', 'EIF4A1', 'CLTC', 'ITPR1', 'CLTA', 'ABAT', 'SLC6A1', 'RPTOR', 'GRIP1', 'PPP3CA', 'GRM5', 'FYN', 'PRKACA', 'GABRD', 'AP2M1', 'EPHA4', 'NTRK2', 'MAP2K1', 'SLC16A1', 'HOMER1', 'KCND2', 'GAD1', 'GAB1', 'PPP2R5B', 'PRKCA', 'BRAF', 'AP2B1', 'GRIN2B', 'DNM2', 'ARHGAP32', 'ALDH5A1', 'RPS6KB1', 'PRKAR1A', 'PLCB1', 'EIF4G1', 'HCN1']",0.3111480976298906,0,0,37
25,Cysteine and methionine catabolism WP4504,0.013841107545813637,4.947928331466965,21.177688945704862,"['AHCY', 'GOT1', 'GSS', 'ETHE1', 'SUOX', 'CDO1']",0.3111480976298906,0,0,6
26,GABA receptor Signaling WP4159,0.017070663637936002,2.4761503928170594,10.07890736895181,"['GABRA2', 'GABRB1', 'GABBR1', 'SLC32A1', 'GAD1', 'GAD2', 'ABAT', 'AP2B1', 'SLC6A1', 'GABRD', 'GABRG3', 'AP2M1']",0.36500504565825015,0,0,12
27,Aryl Hydrocarbon Receptor Pathway WP2873,0.01820901662037532,2.750467289719626,11.017927456508737,"['NCOA1', 'SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'CDC37', 'AIP', 'EP300', 'BAX']",0.36500504565825015,0,0,10
28,PKC-gamma calcium signaling pathway in ataxia WP4760,0.01830144373593001,2.970067264573991,11.882571839279555,"['GRIA1', 'PLCB4', 'TRPC3', 'GNAQ', 'ITPR1', 'CA8', 'PLCB1', 'GRIA3', 'GRIA4']",0.36500504565825015,0,0,9
29,Splicing factor NOVA regulated synaptic proteins WP4148,0.018834779936101876,2.153883732291158,8.5553341409342,"['NTNG1', 'KCNJ6', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'GRIK2', 'ANK3', 'EFNA5', 'GRIN2B', 'PLCB4', 'CDH2', 'TERF2IP', 'NEO1', 'CLASP1']",0.36500504565825015,0,0,15
30,Leptin and adiponectin WP3934,0.02016878704182576,5.496268656716418,21.45533911785671,"['PRKAG1', 'LEPR', 'ADIPOR1', 'PRKAB1', 'ACACA']",0.3656405908872928,0,0,5
31,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.02016878704182576,5.496268656716418,21.45533911785671,"['SFRP1', 'ZEB2', 'TGFB1', 'NRG3', 'ERBB4']",0.3656405908872928,0,0,5
32,Cell Differentiation - Index expanded WP2023,0.024513442910521512,3.957894736842105,14.677985702655315,"['MEF2A', 'SOX2', 'MEF2C', 'ID2', 'MEF2D', 'RUNX2']",0.41421147227977106,0,0,6
33,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.024513442910521512,3.957894736842105,14.677985702655315,"['RYR1', 'RYR2', 'DAGLA', 'GNAQ', 'ITPR1', 'PLCB1']",0.41421147227977106,0,0,6
34,Pyrimidine metabolism WP4022,0.02637278309975237,1.7274349429683764,6.2799562801168145,"['POLR3GL', 'NME2', 'NME3', 'CTPS1', 'NME4', 'POLE4', 'NME6', 'POLR2A', 'NME7', 'POLE2', 'POLR1C', 'DPYD', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR3H', 'UMPS', 'DCTPP1', 'POLR3K', 'POLR2K']",0.41421147227977106,0,0,23
35,Cell migration and invasion through p75NTR WP4561,0.026533119220768255,2.6997554015491234,9.79838843367263,"['NTRK2', 'TIAM1', 'ARF1', 'JUN', 'TRIO', 'EFNB3', 'AKT3', 'RAC1', 'EFNA5']",0.41421147227977106,0,0,9
36,Endothelin Pathways WP2197,0.026533119220768255,2.6997554015491234,9.79838843367263,"['EDNRA', 'MAP2K1', 'NPY1R', 'ATP2A2', 'PRKCA', 'GNB5', 'PLCB1', 'CALM1', 'MYLK']",0.41421147227977106,0,0,9
37,Ferroptosis WP4313,0.03051685898965364,2.2005237560793116,7.678674821773427,"['MAP1LC3B', 'TF', 'MAP1LC3A', 'GPX4', 'GSS', 'LPCAT3', 'VDAC3', 'VDAC2', 'SLC3A2', 'SAT2', 'ACSL3', 'FTL']",0.463526344653658,0,0,12
38,Cytosolic DNA-sensing pathway WP4655,0.03632609716033135,2.0434131736526946,6.774361904287643,"['DDX58', 'POLR3GL', 'ADAR', 'ISG15', 'NFKB1', 'POLR1C', 'POLR2E', 'TRIM25', 'POLR2F', 'POLR3H', 'POLR3K', 'POLR2K', 'NFKBIB']",0.5085427166516335,0,0,13
39,Genotoxicity pathway WP4286,0.03632609716033135,2.0434131736526946,6.774361904287643,"['GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'GXYLT1', 'ITPR1', 'PPM1D', 'PRKAB1', 'COIL', 'RPS27', 'BLOC1S2', 'ID2', 'RAPGEF2']",0.5085427166516335,0,0,13
40,Alanine and aspartate metabolism WP106,0.03677073071281277,4.121735074626866,13.614309862363617,"['GOT1', 'GAD1', 'GOT2', 'GAD2', 'ABAT']",0.5085427166516335,0,0,5
41,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.03811756316310476,1.9047104580812446,6.222841686536612,"['EIF4A2', 'EIF4A1', 'MAP2K1', 'RPS6', 'PRKCA', 'RPTOR', 'MAPK10', 'RPS6KB1', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PRKACA', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.5085427166516335,0,0,15
42,Rett syndrome causing genes WP4312,0.038741520983296605,1.8108284567393722,5.886719665523565,"['MEF2C', 'KCNJ10', 'SATB2', 'STXBP1', 'BRAF', 'GRIN2B', 'RHOBTB2', 'XAB2', 'TBL1XR1', 'SCN8A', 'IMPDH2', 'TCF4', 'HIVEP2', 'HAP1', 'SCN2A', 'GABRD', 'SCN1A']",0.5085427166516335,0,0,17
43,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.03952733339852935,3.297872340425532,10.65464347978833,"['CD63', 'CD81', 'SPP1', 'SORBS2', 'PDLIM5', 'SOD1']",0.5085427166516335,0,0,6
44,Mitochondrial complex III assembly WP4921,0.0398147322645407,2.886062359970127,9.303274768184016,"['UQCRB', 'UQCC3', 'UQCC2', 'LYRM7', 'UQCR11', 'UQCR10', 'UQCRH']",0.5085427166516335,0,0,7
45,ACE Inhibitor Pathway WP554,0.041702835732287356,9.88814317673378,31.41647154358329,"['TGFB1', 'ATP6AP2', 'NR3C2']",0.5094998626422934,0,0,3
46,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.041702835732287356,9.88814317673378,31.41647154358329,"['ID2', 'TCF4', 'RUNX2']",0.5094998626422934,0,0,3
47,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.05425071840054094,inf,inf,"['TGFB1', 'VIP']",0.6222225253286532,0,0,2
48,EV release from cardiac cells and their functional effects WP3297,0.05425071840054094,inf,inf,"['ERBB4', 'RGS16']",0.6222225253286532,0,0,2
49,Nanomaterial-induced inflammasome activation WP3890,0.05425071840054094,inf,inf,"['NFKB1', 'CTSB']",0.6222225253286532,0,0,2
50,Osteoclast Signaling WP12,0.05583112195396108,4.395374860126818,12.682519336663333,"['AIMP2', 'ATP6V1G1', 'SPP1', 'IFNAR1']",0.6260345149381101,0,0,4
51,Pathogenic Escherichia coli infection WP2272,0.05693712900424507,1.8653020046862796,5.345596698305173,"['ROCK1', 'PRKCA', 'ARPC4', 'ACTG1', 'CDC42', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'NCK2', 'ABL1', 'FYN']",0.6260345149381101,0,0,13
52,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.05792490173804577,1.6107628243261796,4.588431714504546,"['MAP2K1', 'THRA', 'RPS6', 'ITPR2', 'ADCY8', 'FOXO1', 'RPTOR', 'SLCO1C1', 'CREB3', 'RPS6KA6', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'AKT3', 'PPARG', 'PRKACA', 'PLCB1', 'MAP4K5', 'HRAS', 'MGLL']",0.6260345149381101,0,0,20
53,RalA downstream regulated genes WP2290,0.059700381024764146,3.2970149253731345,9.292362507017335,"['CDC42', 'RALBP1', 'RAC1', 'HRAS', 'EXOC2']",0.6330493233191972,0,0,5
54,TGF-beta Receptor Signaling WP560,0.06277473206427851,1.8855218855218856,5.219506665312778,"['TGFBR3', 'SMAD2', 'ZEB2', 'JUN', 'TGFB1', 'ZFYVE9', 'STAT1', 'SPP1', 'EP300', 'HRAS', 'RUNX2', 'NFKB1']",0.6533222114837874,0,0,12
55,G Protein Signaling Pathways WP35,0.06945205594049503,1.4954797813277743,3.9886219512390073,"['PDE4D', 'PRKCE', 'ITPR1', 'PRKCA', 'AKAP6', 'ADCY2', 'ADCY8', 'AKAP13', 'PPP3CA', 'GNG10', 'ADCY9', 'GNAL', 'PRKAR1A', 'GNG4', 'GNB2', 'GNAQ', 'AKAP9', 'GNB1', 'PRKD1', 'GNB5', 'PRKACA', 'CALM1', 'HRAS', 'KCNJ3']",0.687408228303503,0,0,24
56,Selenium Micronutrient Network WP15,0.06971933988131615,1.787378368263473,4.760284639574462,"['GPX4', 'KMO', 'SELENOK', 'NFKB1', 'SELENOH', 'SOD1', 'SELENOM', 'SELENOS', 'SELENOP', 'SELENOW', 'PNPO', 'SELENOT', 'SEPHS2']",0.687408228303503,0,0,13
57,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.06971933988131615,1.787378368263473,4.760284639574462,"['SMAD2', 'JUN', 'TGFB1', 'ZFYVE9', 'STAT1', 'RUNX2', 'NFKB1', 'TGFBR3', 'ZEB2', 'SPP1', 'EP300', 'HRAS', 'FBN1']",0.687408228303503,0,0,13
58,VEGFA-VEGFR2 Signaling Pathway WP3888,0.07227481375126944,1.2117580713379388,3.183627222219754,"['RPL5', 'ARF4', 'ITGB5', 'TRAF3IP2', 'CLTC', 'LDB2', 'RPL10A', 'SLC8A1', 'RPL7', 'HERPUD1', 'ACTG1', 'PPP3CA', 'RPL18A', 'TMSB4X', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'ACP1', 'HRAS', 'MAP3K5', 'EIF2A', 'MEF2C', 'MAP2K1', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCE', 'IGFBP3', 'SSR3', 'RPS6', 'GAB1', 'SARS', 'RPL13A', 'PRKCA', 'PDIA6', 'SND1', 'RCN1', 'PIK3CA', 'KATNAL2', 'FSCN1', 'NUMB', 'MYH9', 'RPL27', 'PRKD1', 'RPL26', 'TKT', 'ATP6V0D1', 'PTMA', 'ATF4', 'SET', 'ROCK1', 'EPB41', 'PXN', 'ACACB', 'FOXO1', 'ACACA', 'CDC42', 'LDHA', 'DHX36', 'ABL1', 'DNAJB9', 'RICTOR', 'FYN', 'ASCC3', 'CCT7', 'ABCF2', 'SLC25A25', 'ZC3H15', 'TXNDC5', 'JUN', 'STAT1', 'PDE4DIP', 'NFKB1', 'QKI', 'RAB11A', 'DNAJA1', 'AFDN', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'CYCS', 'HYOU1', 'CALR', 'COPG1', 'GRSF1', 'EIF3D', 'EIF4G2', 'EIF4G1']",0.6894664979904941,0,0,90
59,mRNA Processing WP411,0.07355771651525117,1.3674385910102707,3.568583873003156,"['SF3B5', 'SF3B3', 'DHX8', 'SFSWAP', 'RNMT', 'CELF2', 'CSTF2T', 'SNU13', 'YBX1', 'POLR2A', 'SNRPD1', 'SNRPB2', 'TXNL4A', 'HNRNPA1', 'SRPK2', 'SF3A1', 'RNGTT', 'CPSF1', 'NCBP2', 'SUPT5H', 'PTBP2', 'LSM2', 'PRPF4', 'HNRNPM', 'LSM7', 'PRPF6', 'HNRNPK', 'SNRPG', 'CD2BP2', 'SRSF3', 'SNRPE', 'SNRPA1', 'SNRPF', 'CLASRP', 'RBMX', 'SRSF9']",0.6894664979904941,0,0,36
60,3q29 copy number variation syndrome WP4906,0.0736085229171346,1.650243536905208,4.305476244524109,"['DYNC2H1', 'GRIA1', 'JUN', 'TGFB1', 'NCBP2', 'CEP350', 'PXN', 'MYCBP2', 'PIGZ', 'DYNLL2', 'DYNC2LI1', 'TF', 'BRINP1', 'WDR60', 'UBE2N', 'MELTF']",0.6894664979904941,0,0,16
61,Gastrin signaling pathway WP4659,0.08353413605853731,1.4310267017675817,3.55252366635241,"['CDKN1B', 'ROCK1', 'PXN', 'FOXO1', 'CDC42', 'KAT5', 'FYN', 'RAC1', 'PRKACA', 'HRAS', 'MEF2D', 'MEF2C', 'MAP2K1', 'JUN', 'PRKCE', 'RPS6', 'PRKCA', 'NFKB1', 'TJP1', 'PIK3CA', 'RPS6KB1', 'GNAQ', 'TCF4', 'PPARG', 'PRKD1', 'MAP3K11']",0.713352524686621,0,0,26
62,Pregnane X receptor pathway WP2876,0.08390208272344196,2.472844344904815,6.127967544468013,"['NCOA1', 'NCOA2', 'HSP90AA1', 'PSMC5', 'ABCB1', 'FOXO1']",0.713352524686621,0,0,6
63,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.0843721480005167,1.9789237668161435,4.892924499189522,"['EGLN1', 'LDHA', 'PDHA1', 'SLC16A1', 'PKM', 'IGFBP3', 'BAX', 'SLC2A3', 'HIF1AN']",0.713352524686621,0,0,9
64,Calcium Regulation in the Cardiac Cell WP536,0.08458365050929244,1.37285405886989,3.3909691399754998,"['RYR1', 'RYR2', 'CAMK2D', 'YWHAB', 'RGS16', 'ITPR1', 'ITPR2', 'ATP2A2', 'ADCY2', 'CACNA1C', 'ADCY8', 'SLC8A1', 'YWHAQ', 'GNG4', 'PRKACA', 'RGS7', 'KCNJ3', 'PRKCE', 'ATP2B3', 'PRKCA', 'ATP1B2', 'ATP1B1', 'ADCY9', 'PRKAR1A', 'GNB2', 'GNAQ', 'GNB1', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1']",0.713352524686621,0,0,32
65,Target Of Rapamycin (TOR) Signaling WP1471,0.08559436978968636,1.8143418100224382,4.459898504912613,"['RPTOR', 'CDC42', 'IDI1', 'RPS6KB1', 'RRAGC', 'RRAGD', 'PRKAG1', 'RICTOR', 'PRKCA', 'RAC1', 'PRKAB1']",0.713352524686621,0,0,11
66,Vitamin D Receptor Pathway WP2877,0.0861245895027431,1.5296507053592667,3.7506428268147727,"['ABCB1', 'TGFB1', 'CDKN1B', 'GADD45A', 'IGFBP3', 'TPM1', 'CCNC', 'CDKAL1', 'EFNA5', 'SLC8A1', 'FOXO1', 'SFRP1', 'CLMN', 'PNOC', 'CREG2', 'TIMP2', 'SPP1', 'CLPTM1L', 'CD200']",0.713352524686621,0,0,19
67,Dopaminergic Neurogenesis WP2855,0.08631311686599684,4.943512304250559,12.110486433263606,"['SOX2', 'TGFB1', 'ASCL1']",0.713352524686621,0,0,3
68,Mitochondrial fatty acid synthesis pathway WP4317,0.08631311686599684,4.943512304250559,12.110486433263606,"['HSD17B12', 'MCAT', 'ACACA']",0.713352524686621,0,0,3
69,Endochondral Ossification with Skeletal Dysplasias WP4808,0.09047132379859192,1.6497566454511419,3.963907151865501,"['MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5']",0.7242160669871479,0,0,14
70,Endochondral Ossification WP474,0.09047132379859192,1.6497566454511419,3.963907151865501,"['MEF2C', 'TGFB1', 'THRA', 'STAT1', 'GLI3', 'RUNX2', 'IGF1R', 'GHR', 'SPP1', 'SOX6', 'PRKACA', 'CALM1', 'SLC38A2', 'SOX5']",0.7242160669871479,0,0,14
71,miR-509-3p alteration of YAP1/ECM axis WP3967,0.09149348888983541,3.2961581499440507,7.882720911125431,"['EDNRA', 'SPARC', 'PBX3', 'TEAD1']",0.7242160669871479,0,0,4
72,Eukaryotic Transcription Initiation WP405,0.10052069040791392,1.6495134730538923,3.7895785586782047,"['GTF2A2', 'GTF2H2C', 'ILK', 'GTF2H3', 'POLR2A', 'POLR2E', 'POLR2F', 'TAF7', 'POLR2G', 'POLR3H', 'MNAT1', 'POLR3K', 'POLR2K']",0.7846198334617726,0,0,13
73,Disruption of postsynaptic signaling by CNV WP4875,0.1041121290638592,1.7277486910994764,3.908663051659663,"['TJP1', 'RYR2', 'NLGN1', 'CAMK2D', 'NLGN4X', 'DLG2', 'HOMER1', 'NRXN1', 'NRXN3', 'DLGAP1', 'GRIN2B']",0.8015207744368338,0,0,11
74,Melatonin metabolism and effects WP3298,0.10568806907791105,1.8550308295964126,4.168742643996151,"['SULT1A1', 'PER1', 'MAP2', 'CRY2', 'CRY1', 'PRKCA', 'CALM1', 'FOXO1', 'NFKB1']",0.8026580381322433,0,0,9
75,Constitutive Androstane Receptor Pathway WP2875,0.11329366475189953,2.1978350130645765,4.786383614062165,"['SULT1A1', 'NCOA1', 'NCOA2', 'HSP90AA1', 'ABCB1', 'FOXO1']",0.8377768367179939,0,0,6
76,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.11329366475189953,2.1978350130645765,4.786383614062165,"['TJP1', 'JUN', 'PXN', 'ITPR1', 'LPP', 'MYLK']",0.8377768367179939,0,0,6
77,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.12082800795063553,1.4760810384281544,3.1195307232681166,"['MAP2K1', 'JUN', 'CDKN1B', 'STAT1', 'PDE4D', 'RPS6', 'ADCY2', 'BRAF', 'IGF1R', 'MYL12B', 'PIK3CA', 'RPS6KB1', 'APEX1', 'GNAQ', 'GNB1', 'PLCB1', 'HRAS']",0.8818875385487944,0,0,17
78,Nanomaterial induced apoptosis WP2507,0.12437681251845452,2.3544776119402986,4.907766161144114,"['ENDOG', 'CASP6', 'HTRA2', 'BAX', 'CYCS']",0.8890503063840592,0,0,5
79,Biomarkers for pyrimidine metabolism disorders WP4584,0.13527171772319774,2.6366281238343903,5.274494934198426,"['DPYD', 'TK2', 'CKB', 'UMPS']",0.8890503063840592,0,0,4
80,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.1374912010849319,6.589638464405517,13.075130039007744,"['PPARG', 'PPARA']",0.8890503063840592,0,0,2
81,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1374912010849319,6.589638464405517,13.075130039007744,"['BAX', 'IL6ST']",0.8890503063840592,0,0,2
82,Tgif disruption of Shh signaling WP3674,0.1374912010849319,6.589638464405517,13.075130039007744,"['SMAD2', 'GLI3']",0.8890503063840592,0,0,2
83,IL-2 signaling pathway WP49,0.13949967686768106,1.648785046728972,3.247600355292696,"['MAP2K1', 'JUN', 'CCND2', 'RPS6KB1', 'STAT1', 'RPS6', 'FYN', 'GAB2', 'MAPT', 'HRAS']",0.8890503063840592,0,0,10
84,IL1 and megakaryocytes in obesity WP2865,0.14335541343950714,3.295302013422819,6.400887965603976,"['PIK3CA', 'TIMP2', 'NFKB1']",0.8890503063840592,0,0,3
85,Insulin signaling in adipocytes (diabetic condition) WP3635,0.14335541343950714,3.295302013422819,6.400887965603976,"['TBC1D4', 'RPS6KB1', 'RPS6']",0.8890503063840592,0,0,3
86,Insulin signaling in adipocytes (normal condition) WP3634,0.14335541343950714,3.295302013422819,6.400887965603976,"['TBC1D4', 'RPS6KB1', 'RPS6']",0.8890503063840592,0,0,3
87,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.14335541343950714,3.295302013422819,6.400887965603976,"['JUN', 'UBE2N', 'NFKB1']",0.8890503063840592,0,0,3
88,Sulfation Biotransformation Reaction WP692,0.14335541343950714,3.295302013422819,6.400887965603976,"['SULT1A1', 'SULT4A1', 'PAPSS2']",0.8890503063840592,0,0,3
89,Transcriptional cascade regulating adipogenesis WP4211,0.14335541343950714,3.295302013422819,6.400887965603976,"['CEBPB', 'DDIT3', 'PPARG']",0.8890503063840592,0,0,3
90,AGE/RAGE pathway WP2324,0.14368699779994193,1.4895955362857936,2.88999107028883,"['SMAD2', 'MAP2K1', 'JUN', 'ROCK1', 'STAT1', 'PRKCA', 'DDOST', 'TIRAP', 'FOXO1', 'NFKB1', 'SOD1', 'CDC42', 'CYCS', 'RAC1']",0.8890503063840592,0,0,14
91,Hippo-Yap signaling pathway WP4537,0.1471204243660454,1.9778275475923852,3.790514038792755,"['LATS1', 'YWHAQ', 'TNIK', 'TEAD1', 'MAP4K3', 'MAP4K4']",0.8890503063840592,0,0,6
92,Methionine De Novo and Salvage Pathway WP3580,0.1471204243660454,1.9778275475923852,3.790514038792755,"['MSRA', 'AHCY', 'AMD1', 'ODC1', 'SMS', 'SRM']",0.8890503063840592,0,0,6
93,SARS-CoV-2 mitochondrial interactions WP5038,0.1471204243660454,1.9778275475923852,3.790514038792755,"['TOMM70', 'NDUFB9', 'CTSL', 'DDX58', 'PHB', 'NFKB1']",0.8890503063840592,0,0,6
94,Ciliary landscape WP4352,0.15032717675653015,1.205556863668472,2.284459347997421,"['DOCK5', 'IFT172', 'MYL6B', 'DCAF7', 'RPGR', 'PSMD8', 'PSMD7', 'APMAP', 'BBS9', 'RAC1', 'CEP290', 'BBS4', 'ACSL3', 'DYNLL2', 'MSH2', 'TBC1D4', 'TIPRL', 'EXOC4', 'CD2BP2', 'MCM4', 'EXOC2', 'PAFAH1B1', 'ARL8B', 'ECHS1', 'VPS4A', 'HTRA2', 'COPS7A', 'EHBP1', 'PGRMC2', 'RMND5A', 'SNRPB2', 'DCAF11', 'RNGTT', 'NDUFA5', 'EXOC6B', 'COX6C', 'LSM4', 'NFKB1', 'AIMP1', 'COPS4', 'MKLN1', 'COPS6', 'PSMC6', 'RAB14', 'MFAP1', 'WNK1', 'WDR60', 'GID8', 'CALM1', 'COPS8']",0.898764609969893,0,0,50
95,BDNF-TrkB Signaling WP3676,0.15640030949241077,1.6485426008968609,3.0586012131245575,"['NTRK2', 'MAP2K1', 'TRPC3', 'HOMER1', 'RPS6KB1', 'GAB1', 'BRAF', 'GAB2', 'HRAS']",0.9190584944925079,0,0,9
96,Estrogen signaling pathway WP712,0.1635982664737806,1.775033032687999,3.2134158759616285,"['MAP2K1', 'JUN', 'PIK3CA', 'GNB1', 'BRAF', 'PRKACA', 'NFKB1']",0.9190584944925079,0,0,7
97,Genes controlling nephrogenesis WP4823,0.1635982664737806,1.775033032687999,3.2134158759616285,"['EYA1', 'NCK2', 'ILK', 'SLIT2', 'GLI3', 'FGFR2', 'CD2AP']",0.9190584944925079,0,0,7
98,Physiological and pathological hypertrophy of the heart WP1528,0.1635982664737806,1.775033032687999,3.2134158759616285,"['PPP3CA', 'CAMK2D', 'JUN', 'PRKCE', 'RAC1', 'IL6ST', 'CALM1']",0.9190584944925079,0,0,7
99,Acute viral myocarditis WP4298,0.1645472060996885,1.4428818794459004,2.603763725175591,"['ENDOG', 'CXADR', 'TGFB1', 'STAT1', 'ILK', 'SGCD', 'CASP6', 'ABL1', 'CYCS', 'BAX', 'DMD', 'FYN', 'EIF4G2', 'EIF4G1']",0.9190584944925079,0,0,14
100,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.16506428007441645,2.059934701492537,3.710808197703232,"['PLP1', 'MBP', 'ASCL1', 'SOX6', 'SOX5']",0.9190584944925079,0,0,5
101,Vitamin D-sensitive calcium signaling in depression WP4698,0.16516887534473898,1.5700934579439252,2.827403639068214,"['GRM5', 'GPX4', 'ITPR1', 'KCNQ3', 'ITPR2', 'ATP2B3', 'CACNA1C', 'GRIN2B', 'SLC8A1', 'PVALB']",0.9190584944925079,0,0,10
102,7q11.23 copy number variation syndrome WP4932,0.18405039554681393,1.2960007510326699,2.1935404595191783,"['ATP5PB', 'CLTC', 'UBE2E1', 'ATP5MC2', 'ATP5MC3', 'DDX21', 'UBE2L6', 'ACACB', 'ACACA', 'ATP5F1E', 'ATP5MC1', 'GRIP1', 'CLIP2', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'BUD23', 'SQSTM1', 'CLASP1', 'EIF2A', 'ATF4', 'FBN1']",0.9964075375310776,0,0,22
103,Apoptosis Modulation and Signaling WP1772,0.1929314464336864,1.3529699974061158,2.226204370731883,"['HRK', 'JUN', 'ENDOG', 'CRADD', 'HTRA2', 'PTPN13', 'NFKB1', 'CASP6', 'TOLLIP', 'MADD', 'CYCS', 'BAX', 'BIRC6', 'PRKD1', 'BCL2L2', 'MAP3K5']",0.9964075375310776,0,0,16
104,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.1929314464336864,1.3529699974061158,2.226204370731883,"['PRKN', 'HSPA9', 'PSMD14', 'HSPA5', 'HSPA4', 'UBE2L6', 'PSMD8', 'TUBB2B', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMC6', 'PSMD2', 'RNF19A', 'PSMC1']",0.9964075375310776,0,0,16
105,Metabolic reprogramming in colon cancer WP4290,0.1988438487932533,1.4506507105459985,2.343142441216533,"['LDHA', 'PDHA1', 'PKM', 'MDH2', 'PGAM1', 'GOT2', 'TALDO1', 'PYCR2', 'PDHB', 'TKT', 'GLS']",0.9964075375310776,0,0,11
106,Pathways Regulating Hippo Signaling WP4540,0.20003974009524245,1.2934554684913364,2.081479284348264,"['SMAD2', 'NTRK2', 'PRKCE', 'PRKAG1', 'PRKCA', 'PRKAB1', 'IGF1R', 'LATS1', 'CDC42', 'GNAL', 'PLCB4', 'CDH2', 'PRKAR1A', 'GNAQ', 'RAC1', 'PRKACA', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18']",0.9964075375310776,0,0,20
107,15q13.3 copy number variation syndrome WP4942,0.20899864488630251,2.4711968680089487,3.8684795618728236,"['KAT2B', 'OTUD7A', 'FYN']",0.9964075375310776,0,0,3
108,Cancer immunotherapy by PD-1 blockade WP4585,0.20899864488630251,2.4711968680089487,3.8684795618728236,"['JUN', 'HLA-A', 'NFKB1']",0.9964075375310776,0,0,3
109,Cell Differentiation - Index WP2029,0.20899864488630251,2.4711968680089487,3.8684795618728236,"['MEF2A', 'MEF2C', 'MEF2D']",0.9964075375310776,0,0,3
110,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.20899864488630251,2.4711968680089487,3.8684795618728236,"['UBE2N', 'SQSTM1', 'NFKB1']",0.9964075375310776,0,0,3
111,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.20902653228463375,1.5511657034872224,2.4280305026086904,"['MAP2K1', 'PIK3CA', 'STAT1', 'RPS6', 'STAT4', 'FYN', 'GAB2', 'NFKB1']",0.9964075375310776,0,0,8
112,Imatinib and Chronic Myeloid Leukemia WP3640,0.21015439506009612,1.8308457711442787,2.8559597602471007,"['ABCB1', 'CDKN1B', 'GADD45A', 'ABL1', 'GAB2']",0.9964075375310776,0,0,5
113,Overview of interferons-mediated signaling pathway WP4558,0.21015439506009612,1.8308457711442787,2.8559597602471007,"['PIK3CA', 'STAT1', 'IFNGR2', 'PRKCA', 'IFNAR1']",0.9964075375310776,0,0,5
114,Head and Neck Squamous Cell Carcinoma WP4674,0.2150621966978805,1.3189958786062195,2.0270698056752456,"['RPS6', 'GAB1', 'NFKB1', 'IGF1R', 'RPTOR', 'CDK6', 'PIK3CA', 'SESN1', 'SESN2', 'AKT3', 'NUMB', 'FAT1', 'RICTOR', 'CSMD3', 'HRAS', 'FGFR2']",0.9964075375310776,0,0,16
115,16p11.2 proximal deletion syndrome WP4949,0.21668608560503239,1.3037027997629091,1.9937599701293494,"['CCT3', 'CCT2', 'IGFBP3', 'QPRT', 'KIF22', 'SEZ6L2', 'NFKB1', 'CCT6A', 'PPP4R4', 'TCP1', 'TMEM219', 'PPARG', 'CCT7', 'CDIPT', 'CCT5', 'CCT4', 'BPTF']",0.9964075375310776,0,0,17
116,Mitochondrial CIV Assembly WP4922,0.21669149387113812,1.4833520179372197,2.2684614999403063,"['COA3', 'COX7B', 'NDUFA4', 'COX17', 'COX14', 'COX6C', 'COX7C', 'PET117', 'COX6B1']",0.9964075375310776,0,0,9
117,IL-3 signaling pathway WP286,0.22254851552046953,1.4332385209264527,2.1535987544497934,"['MAP2K1', 'JUN', 'TGFB1', 'YWHAQ', 'YWHAB', 'IL3RA', 'FYN', 'GAB2', 'PRKACA', 'HRAS']",0.9964075375310776,0,0,10
118,White fat cell differentiation WP4149,0.22590200549863837,1.6478163493840985,2.4513805467323677,"['TLE3', 'CEBPB', 'DDIT3', 'RORA', 'PPARG', 'FOXO1']",0.9964075375310776,0,0,6
119,Arylamine metabolism WP694,0.23295135192813188,inf,inf,['SULT1A1'],0.9964075375310776,0,0,1
120,Codeine and Morphine Metabolism WP1604,0.23295135192813188,inf,inf,['ABCB1'],0.9964075375310776,0,0,1
121,Metastatic brain tumor WP2249,0.23327957681787098,3.294446515095043,4.795125030646173,"['CDC42', 'CDK6']",0.9964075375310776,0,0,2
122,"Phase I biotransformations, non P450 WP136",0.23327957681787098,3.294446515095043,4.795125030646173,"['PON2', 'CES2']",0.9964075375310776,0,0,2
123,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.23327957681787098,3.294446515095043,4.795125030646173,"['SLIT2', 'RAC1']",0.9964075375310776,0,0,2
124,Senescence and Autophagy in Cancer WP615,0.24010185500897308,1.2530307576894224,1.7876890201502198,"['GABARAPL2', 'GABARAPL1', 'MAP2K1', 'JUN', 'CEBPB', 'SPARC', 'TGFB1', 'CDKN1B', 'IGFBP3', 'BRAF', 'CXCL14', 'GABARAP', 'IGF1R', 'RSL1D1', 'MAP1LC3B', 'MAP1LC3A', 'IL6ST', 'SQSTM1', 'HRAS']",0.9964075375310776,0,0,19
125,Adipogenesis WP236,0.24027418767641062,1.2443626323055683,1.7744294559453806,"['MEF2A', 'NCOA1', 'CNTFR', 'NCOA2', 'MEF2C', 'MBNL1', 'CEBPB', 'TGFB1', 'GADD45A', 'STAT1', 'CISD1', 'RORA', 'FOXO1', 'BSCL2', 'DDIT3', 'NDN', 'PPARG', 'IL6ST', 'PPARA', 'MEF2D']",0.9964075375310776,0,0,20
126,Cori Cycle WP1946,0.24086963421873536,1.8828795225662067,2.6802779246883004,"['LDHA', 'PGAM1', 'TALDO1', 'PFKP']",0.9964075375310776,0,0,4
127,TP53 network WP1742,0.24086963421873536,1.8828795225662067,2.6802779246883004,"['SUMO1', 'GADD45A', 'ABL1', 'BAX']",0.9964075375310776,0,0,4
128,Neural Crest Cell Migration in Cancer WP4565,0.24977370044009278,1.4125560538116593,1.9594977144804369,"['NTRK2', 'TIAM1', 'ARF1', 'JUN', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'EPHB1']",0.9964075375310776,0,0,9
129,Hepatitis B infection WP4666,0.25582668177521145,1.1872686230248306,1.6185499912831798,"['YWHAB', 'YWHAQ', 'AKT3', 'STAT4', 'EP300', 'HRAS', 'SMAD2', 'MAP2K1', 'JUN', 'TGFB1', 'ATP6AP1', 'DDX58', 'STAT1', 'PRKCA', 'BRAF', 'NFKB1', 'TIRAP', 'MAPK10', 'CREB3', 'PIK3CA', 'VDAC3', 'CYCS', 'BAX', 'TAB2', 'IFNAR1', 'ATF4', 'CREB5']",0.9964075375310776,0,0,27
130,RANKL/RANK signaling pathway WP2018,0.25675405705017856,1.3428903847752016,1.825842955522689,"['CDC42', 'MAP2K1', 'JUN', 'STAT1', 'MITF', 'TAB2', 'RAC1', 'GAB2', 'SQSTM1', 'PAPSS2', 'NFKB1']",0.9964075375310776,0,0,11
131,Type II interferon signaling (IFNG) WP619,0.25858475941216974,1.6475746268656717,2.2283969922903695,"['STAT1', 'IFNGR2', 'HLA-B', 'EIF2AK2', 'ISG15']",0.9964075375310776,0,0,5
132,Energy Metabolism WP1541,0.2588938569660631,1.3185185185185184,1.7817630174090515,"['ESRRA', 'NCOA1', 'MEF2A', 'PPP3CA', 'MEF2C', 'PRKAG1', 'EP300', 'PPARG', 'PPARA', 'MEF2D', 'PRKAB1', 'FOXO1']",0.9964075375310776,0,0,12
133,Toll-like Receptor Signaling Pathway WP75,0.261439473484035,1.281979283664046,1.7198424888721158,"['MAP2K1', 'JUN', 'STAT1', 'NFKB1', 'TIRAP', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'SPP1', 'TAB2', 'RAC1', 'IFNAR1', 'NFKBIB']",0.9964075375310776,0,0,14
134,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.2669460798104718,1.1597900779958827,1.531744717737914,"['GRIA1', 'RAB3A', 'DOCK3', 'YBX1', 'ACACB', 'CDC42', 'GRIP1', 'CDH2', 'DPYSL2', 'NCK2', 'RACK1', 'SPP1', 'KCNN2', 'FYN', 'RAC1', 'HRAS', 'GRIA3', 'MEF2A', 'NTRK2', 'MEF2C', 'MAP2K1', 'JUN', 'STAT1', 'RPS6', 'EIF2S2', 'GRIN2B', 'NFKB1', 'MAPK10', 'TIAM1', 'RPS6KB1', 'MAPT', 'SQSTM1']",0.9964075375310776,0,0,32
135,DNA Mismatch Repair WP531,0.2694887209441938,1.5208889654578344,1.994233323823633,"['POLE4', 'MSH2', 'RPA3', 'POLE2', 'POLD2', 'RPA2']",0.9964075375310776,0,0,6
136,Estrogen Receptor Pathway WP2881,0.2795017353402416,1.9767337807606264,2.519835017346953,"['JUN', 'ACOX1', 'PPARA']",0.9964075375310776,0,0,3
137,Serotonin and anxiety-related events WP3944,0.2795017353402416,1.9767337807606264,2.519835017346953,"['PPP3CA', 'NLGN1', 'CRH']",0.9964075375310776,0,0,3
138,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2812597860747365,1.3875705326071996,1.7601006559087236,"['MAP2K1', 'PLCB4', 'PIK3CA', 'PRKCE', 'PRKCA', 'PLCB1', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,8
139,Neural Crest Cell Migration during Development WP4564,0.2812597860747365,1.3875705326071996,1.7601006559087236,"['TIAM1', 'ARF1', 'JUN', 'TRIO', 'PIK3CA', 'AKT3', 'RAC1', 'EPHB1']",0.9964075375310776,0,0,8
140,Prion disease pathway WP3995,0.2812597860747365,1.3875705326071996,1.7601006559087236,"['PDIA3', 'MEF2C', 'HSPA5', 'EP300', 'FYN', 'CHD2', 'NFKB1', 'HSP90B1']",0.9964075375310776,0,0,8
141,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.28438476221636555,1.348196086424786,1.6952583776849057,"['RPTOR', 'SMAD2', 'MAP1LC3A', 'RPS6KB1', 'ILK', 'RICTOR', 'PRKAB1', 'NFKB1', 'IGF1R']",0.9964075375310776,0,0,9
142,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.28438476221636555,1.348196086424786,1.6952583776849057,"['LATS1', 'MAPK10', 'ITGB5', 'YWHAQ', 'MAP4K5', 'TEAD1', 'MAP4K3', 'ACTG1', 'MAP4K4']",0.9964075375310776,0,0,9
143,Interleukin-11 Signaling Pathway WP2332,0.2864161800681074,1.3182803738317757,1.6482582784309787,"['ATF1', 'MAP2K1', 'TGFB1', 'RPS6KB1', 'STAT1', 'RPS6', 'FYN', 'IL6ST', 'HRAS', 'RUNX2']",0.9964075375310776,0,0,10
144,miRNA targets in ECM and membrane receptors WP2911,0.2991160389948605,1.6473330846698993,1.9882053261893569,"['ITGB5', 'COL4A2', 'COL4A1', 'COL5A2']",0.9964075375310776,0,0,4
145,Phytochemical activity on NRF2 transcriptional activation WP3,0.2991160389948605,1.6473330846698993,1.9882053261893569,"['AIMP2', 'CEBPB', 'PIK3CA', 'PRKCA']",0.9964075375310776,0,0,4
146,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2991160389948605,1.6473330846698993,1.9882053261893569,"['LDHA', 'PDHA1', 'PIK3CA', 'SLC2A3']",0.9964075375310776,0,0,4
147,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.2991160389948605,1.6473330846698993,1.9882053261893569,"['SMAD2', 'TGFB1', 'CDH2', 'RUNX2']",0.9964075375310776,0,0,4
148,Urea cycle and metabolism of amino groups WP497,0.2991160389948605,1.6473330846698993,1.9882053261893569,"['ODC1', 'SMS', 'CKB', 'SRM']",0.9964075375310776,0,0,4
149,Pre-implantation embryo WP3527,0.30925035964256675,1.4976255088195387,1.7576194445428655,"['SOX2', 'ESRRA', 'DDIT3', 'ATP1A1', 'NR3C2']",0.9964075375310776,0,0,5
150,PI3K-Akt signaling pathway WP4172,0.31487196598840544,1.0993176648976497,1.2703595988971224,"['CDKN1B', 'HSP90AB1', 'ITGB5', 'EFNA5', 'IGF1R', 'HSP90B1', 'RPTOR', 'GHR', 'GNG10', 'RELN', 'CCND2', 'PPP2R5E', 'GNG4', 'PPP2R3C', 'AKT3', 'SPP1', 'RAC1', 'HRAS', 'EIF4B', 'NTRK2', 'MAP2K1', 'HSP90AA1', 'RPS6', 'PPP2R5B', 'PRKCA', 'VEGFD', 'NFKB1', 'CREB3', 'CDK6', 'FGF14', 'COL4A2', 'PIK3CA', 'RPS6KB1', 'COL4A1', 'PPP2R2B', 'CDC37', 'GNB2', 'GNB1', 'IL3RA', 'PPP2R2D', 'GNB5', 'EIF4E2', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1', 'CREB5']",0.9964075375310776,0,0,47
151,Allograft Rejection WP2328,0.3179865735601175,1.3567631682994332,1.55450613394174,"['ABCB1', 'TGFB1', 'STAT1', 'HLA-B', 'HLA-C', 'HLA-A', 'HLA-F']",0.9964075375310776,0,0,7
152,Lipid Metabolism Pathway WP3965,0.3179865735601175,1.3567631682994332,1.55450613394174,"['PDHA1', 'PRKAR1A', 'AKT3', 'PRKAG1', 'PRKACA', 'PRKAB1', 'ACACA']",0.9964075375310776,0,0,7
153,Interferon type I signaling pathways WP585,0.31865256621936217,1.2358305274971941,1.41336240726105,"['RPTOR', 'EIF4A1', 'RPS6KB1', 'STAT1', 'RPS6', 'RACK1', 'STAT4', 'FYN', 'RAC1', 'GAB2', 'EIF4B', 'IFNAR1']",0.9964075375310776,0,0,12
154,Aryl Hydrocarbon Receptor Netpath WP2586,0.3201745550262433,1.2894326379411192,1.468520579837492,"['HSP90AA1', 'MAP2K1', 'CDKN1B', 'CDC37', 'AIP', 'EP300', 'NCOA7', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,9
155,Nephrotic syndrome WP4758,0.3201745550262433,1.2894326379411192,1.468520579837492,"['SCARB2', 'YARS', 'CUBN', 'ANLN', 'TTC21B', 'PDSS2', 'MYH9', 'WDR73', 'CD2AP']",0.9964075375310776,0,0,9
156,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.32961610929094487,1.0914505226964517,1.2113208301655096,"['CDKN1B', 'HSP90AB1', 'ITGB5', 'COL11A1', 'SLC2A3', 'EFNA5', 'FOXO1', 'ACACA', 'IGF1R', 'HSP90B1', 'RPTOR', 'GHR', 'GNG10', 'RELN', 'PPP2R5E', 'GNG4', 'PPP2R3C', 'AKT3', 'SPP1', 'HRAS', 'EIF4B', 'MAP2K1', 'HSP90AA1', 'RPS6', 'PPP2R5B', 'VEGFD', 'CREB3', 'FGF14', 'COL4A2', 'PIK3CA', 'RAB14', 'PIK3IP1', 'RPS6KB1', 'COL4A1', 'PPP2R2B', 'CDC37', 'GNB2', 'COL5A2', 'GNB1', 'IL3RA', 'PPP2R2D', 'EIF4E2', 'FGF12', 'FGFR2', 'ATF4', 'IFNAR1', 'CREB5']",0.9964075375310776,0,0,47
157,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.33125719797581954,2.1960491986582182,2.4263272957441044,"['CEBPB', 'ALDH1L1']",0.9964075375310776,0,0,2
158,NAD Biosynthesis II (from tryptophan) WP2485,0.33125719797581954,2.1960491986582182,2.4263272957441044,"['QPRT', 'KMO']",0.9964075375310776,0,0,2
159,Peroxiredoxin 2 induced ovarian failure WP4873,0.33125719797581954,2.1960491986582182,2.4263272957441044,"['MAPK10', 'BAX']",0.9964075375310776,0,0,2
160,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.33125719797581954,2.1960491986582182,2.4263272957441044,"['FOXO1', 'IGF1R']",0.9964075375310776,0,0,2
161,Vitamin B12 Disorders WP4271,0.33125719797581954,2.1960491986582182,2.4263272957441044,"['CUBN', 'MMAB']",0.9964075375310776,0,0,2
162,Leptin signaling pathway WP2034,0.3368579605157804,1.1672366941529235,1.2700631496737391,"['NCOA1', 'MAP2K1', 'ROCK1', 'STAT1', 'RPS6', 'ACACB', 'FOXO1', 'ACACA', 'NFKB1', 'CDC42', 'RPS6KB1', 'CFL2', 'LEPR', 'BAX', 'FYN', 'RAC1', 'HRAS']",0.9964075375310776,0,0,17
163,Pathways in clear cell renal cell carcinoma WP4018,0.3368579605157804,1.1672366941529235,1.2700631496737391,"['SETD2', 'TGFB1', 'BHLHE41', 'PLOD2', 'ACACB', 'ACACA', 'RPTOR', 'LDHA', 'PKM', 'ZEB1', 'EP300', 'ALDOC', 'CEP290', 'SQSTM1', 'PFKM', 'KCNJ2', 'PFKP']",0.9964075375310776,0,0,17
164,Chemokine signaling pathway WP3929,0.3378520378709084,1.1288495210629312,1.2249679389072599,"['ROCK1', 'PXN', 'ADCY2', 'ADCY8', 'CXCL14', 'CDC42', 'GNG10', 'GNG4', 'AKT3', 'RAC1', 'HRAS', 'MAP2K1', 'STAT1', 'BRAF', 'NFKB1', 'TIAM2', 'TIAM1', 'ADCY9', 'PLCB4', 'PIK3CA', 'GNB2', 'GNB1', 'GNB5', 'PLCB1', 'NFKBIB']",0.9964075375310776,0,0,25
165,Prolactin Signaling Pathway WP2037,0.3420005994697621,1.1769662921348314,1.2628174961427732,"['MAP2K1', 'JUN', 'STAT1', 'RPS6', 'PXN', 'GAB2', 'NFKB1', 'PIK3CA', 'RPS6KB1', 'RPS6KA2', 'FYN', 'RAC1', 'PPIB', 'HRAS', 'NFKBIB']",0.9964075375310776,0,0,15
166,Ebola Virus Pathway on Host WP4217,0.3496900107028248,1.1346182247821592,1.192152673390606,"['DDX58', 'STAT1', 'CLTC', 'VPS4A', 'HLA-B', 'DAB2IP', 'HLA-C', 'EIF2AK2', 'CLTA', 'HLA-A', 'HLA-F', 'NFKB1', 'IGF1R', 'ACTG1', 'CDC42', 'TIAM1', 'PIK3CA', 'CTSL', 'EP300', 'RAC1', 'CTSB']",0.9964075375310776,0,0,21
167,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['SFRP1', 'SST', 'FOXO1']",0.9964075375310776,0,0,3
168,Development and heterogeneity of the ILC family WP3893,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['ID2', 'RORA', 'TOX']",0.9964075375310776,0,0,3
169,Genes targeted by miRNAs in adipocytes WP1992,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['TMSB4X', 'PTBP2', 'KCNJ2']",0.9964075375310776,0,0,3
170,Major receptors targeted by epinephrine and norepinephrine WP4589,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['ADCY9', 'ADCY2', 'ADCY8']",0.9964075375310776,0,0,3
171,miRNAs involved in DNA damage response WP1545,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['CDKN1B', 'CDK6', 'ABL1']",0.9964075375310776,0,0,3
172,Non-homologous end joining WP438,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['XRCC6', 'DCLRE1C', 'XRCC5']",0.9964075375310776,0,0,3
173,Pyrimidine metabolism and related diseases WP4225,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['DPYD', 'TK2', 'UMPS']",0.9964075375310776,0,0,3
174,TCA cycle in senescence WP5050,0.35161672840074365,1.6470917225950783,1.7215625641015453,"['PDHA1', 'GOT1', 'BRAF']",0.9964075375310776,0,0,3
175,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.35216464443685946,1.2081899775617053,1.26093529053023,"['SMAD2', 'MAP2K1', 'TGFB1', 'ADCY9', 'ADCY2', 'BANF1', 'ADCY8', 'HRAS', 'EMD', 'SYNE1', 'PLEC']",0.9964075375310776,0,0,11
176,p53 transcriptional gene network WP4963,0.35216464443685946,1.2081899775617053,1.26093529053023,"['MSH2', 'SIVA1', 'XRCC5', 'MGMT', 'GADD45A', 'SESN1', 'SESN2', 'BAX', 'FANCC', 'ISG15', 'PRKAB1']",0.9964075375310776,0,0,11
177,Common Pathways Underlying Drug Addiction WP2636,0.35455143635534625,1.2203530633437176,1.2653863466345745,"['GRIA1', 'GRM5', 'MAP2K1', 'PRKCA', 'ADCY8', 'PRKACA', 'CALM1', 'GRIA3', 'ACTG1', 'GRIA4']",0.9964075375310776,0,0,10
178,Apoptosis Modulation by HSP70 WP384,0.35869458487450645,1.464130299639438,1.5011493570877237,"['MAPK10', 'CASP6', 'CYCS', 'NFKB1']",0.9964075375310776,0,0,4
179,Globo Sphingolipid Metabolism WP1424,0.35869458487450645,1.464130299639438,1.5011493570877237,"['B3GALNT1', 'ST8SIA1', 'ST6GALNAC3', 'ST6GALNAC5']",0.9964075375310776,0,0,4
180,Nicotine Activity on Dopaminergic Neurons WP1602,0.35869458487450645,1.464130299639438,1.5011493570877237,"['CHRNA4', 'GNB1', 'ADCY2', 'PRKACA']",0.9964075375310776,0,0,4
181,Type 2 papillary renal cell carcinoma WP4241,0.3587708086751327,1.2551363466567054,1.2866045105183892,"['EGLN1', 'SETD2', 'EGLN3', 'TGFB1', 'CADM2', 'EP300', 'ELOB', 'ELOC']",0.9964075375310776,0,0,8
182,Pancreatic adenocarcinoma pathway WP4263,0.3593277531845575,1.1407372155403652,1.1675677489436382,"['SMAD2', 'RALBP1', 'MAP2K1', 'TGFB1', 'STAT1', 'GADD45A', 'PEBP1', 'BRAF', 'NFKB1', 'CDC42', 'MAPK10', 'TIAM1', 'CDK6', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'RAC1']",0.9964075375310776,0,0,18
183,Nuclear receptors WP170,0.3603599135789375,1.2812422205626088,1.307702418268088,"['ESRRA', 'THRA', 'NR1H2', 'RORA', 'ROR1', 'PPARG', 'PPARA']",0.9964075375310776,0,0,7
184,Oxidative Stress WP408,0.3610751242753915,1.3726679104477613,1.398294579597281,"['MAPK10', 'NFIX', 'NFKB1', 'TXN2', 'SOD1']",0.9964075375310776,0,0,5
185,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.36129058904652733,1.3178051511758118,1.3416214333676235,"['RAB3A', 'HSPB8', 'MFN2', 'SBF2', 'RAB11A', 'DNM2']",0.9964075375310776,0,0,6
186,Amino Acid metabolism WP3925,0.3661870422614867,1.1461710134067473,1.1514560442708222,"['WARS', 'PDHA1', 'PPM1L', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'GOT2', 'GLS', 'SRM', 'LDHA', 'PKM', 'SMS', 'IARS', 'BCAT1', 'GLUL']",0.9964075375310776,0,0,16
187,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3811909103810627,1.162870535419555,1.1215362466958851,"['SCARB2', 'CDKN1B', 'TGFB1', 'YWHAQ', 'CDH2', 'CTSL', 'FAT1', 'ILK', 'MYH9', 'FYN', 'PARVA', 'CD2AP']",0.9964075375310776,0,0,12
188,TNF-alpha signaling pathway WP231,0.38889027010786315,1.1202923538230884,1.0580691399219238,"['HSP90AA1', 'JUN', 'KSR2', 'TANK', 'NFKB1', 'PSMD2', 'CDC37', 'MADD', 'BAX', 'TAB2', 'RAC1', 'BTRC', 'GLUL', 'HRAS', 'MAP3K5', 'SKP1', 'NFKBIB']",0.9964075375310776,0,0,17
189,Ras signaling WP4223,0.3895335918382044,1.0767886743425474,1.0152019333703535,"['RAB5B', 'RAB5C', 'RASAL2', 'IGF1R', 'CDC42', 'GNG10', 'GNG4', 'AKT3', 'ABL1', 'RAC1', 'PRKACA', 'HRAS', 'NTRK2', 'RALBP1', 'MAP2K1', 'PLA2G4C', 'GAB1', 'PRKCA', 'KSR2', 'GAB2', 'GRIN2B', 'NFKB1', 'MAPK10', 'TIAM1', 'AFDN', 'PIK3CA', 'GNB2', 'GNB1', 'CALM3', 'GNB5', 'CALM1', 'FGFR2', 'EXOC2']",0.9964075375310776,0,0,33
190,Alzheimer's disease WP2059,0.39784367540821913,1.1232124616956078,1.0352605748560633,"['ATP5MD', 'ITPR1', 'ATP2A2', 'ITPR2', 'IDE', 'CACNA1C', 'GRIN2B', 'PPP3CA', 'PLCB4', 'GNAQ', 'CYCS', 'CALM3', 'MAPT', 'PLCB1', 'CALM1']",0.9964075375310776,0,0,15
191,Copper homeostasis WP3286,0.39840610973767154,1.1979488572689918,1.1024524686001418,"['JUN', 'CCS', 'PIK3CA', 'COX17', 'MAPT', 'FOXO1', 'ATOX1', 'SOD1']",0.9964075375310776,0,0,8
192,Parkinson's disease pathway WP2371,0.39840610973767154,1.1979488572689918,1.1024524686001418,"['PRKN', 'ATXN2', 'PINK1', 'CASP6', 'SYT11', 'HTRA2', 'CYCS', 'UBE2L6']",0.9964075375310776,0,0,8
193,PDGFR-beta pathway WP3972,0.40313193698327443,1.213670846271766,1.1026095063154244,"['MAP2K1', 'JUN', 'PIK3CA', 'STAT1', 'EIF2AK2', 'PRKCA', 'HRAS']",0.9964075375310776,0,0,7
194,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4076554032125838,1.1270780806807437,1.0113644245996112,"['RYR2', 'ITGB5', 'ATP2A2', 'CACNA1C', 'SLC8A1', 'ACTG1', 'SGCD', 'CACNB4', 'CDH2', 'DMD', 'CACNG2', 'EMD', 'CACNG4']",0.9964075375310776,0,0,13
195,Resistin as a regulator of inflammation WP4481,0.4080300944119657,1.2353023516237402,1.107342750241597,"['PLCB4', 'PIK3CA', 'AKT3', 'ITPR1', 'PLCB1', 'NFKB1']",0.9964075375310776,0,0,6
196,Drug Induction of Bile Acid Pathway WP2289,0.4116518372309296,3.293591654247392,2.9233173266301073,['ABCB1'],0.9964075375310776,0,0,1
197,Gastric acid production WP2596,0.4116518372309296,3.293591654247392,2.9233173266301073,['VIP'],0.9964075375310776,0,0,1
198,let-7 inhibition of ES cell reprogramming WP3299,0.4116518372309296,3.293591654247392,2.9233173266301073,['SOX2'],0.9964075375310776,0,0,1
199,Metabolism of alpha-linolenic acid WP4586,0.4116518372309296,3.293591654247392,2.9233173266301073,['FADS1'],0.9964075375310776,0,0,1
200,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4130647686013142,1.266934557979334,1.1201612962521008,"['RPS6KB1', 'RPS6', 'PRKCA', 'PRKACA', 'FOXO1']",0.9964075375310776,0,0,5
201,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.4130647686013142,1.266934557979334,1.1201612962521008,"['LATS1', 'YWHAQ', 'RAC1', 'TEAD1', 'FOXO1']",0.9964075375310776,0,0,5
202,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.4130647686013142,1.266934557979334,1.1201612962521008,"['PPP3CA', 'FYN', 'PRKCA', 'CALM1', 'NFKB1']",0.9964075375310776,0,0,5
203,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.4130647686013142,1.266934557979334,1.1201612962521008,"['ADAMTS2', 'CRTAP', 'ITPR1', 'PLOD2', 'PPIB']",0.9964075375310776,0,0,5
204,Peptide GPCRs WP24,0.41811064056439734,1.317568071615069,1.1489314683959941,"['OPRD1', 'EDNRA', 'NPY1R', 'NMBR']",0.9964075375310776,0,0,4
205,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.41811064056439734,1.317568071615069,1.1489314683959941,"['STAT1', 'DDX58', 'EIF2AK2', 'IFNAR1']",0.9964075375310776,0,0,4
206,Vitamin B12 metabolism WP1533,0.41811064056439734,1.317568071615069,1.1489314683959941,"['CUBN', 'MMAB', 'NFKB1', 'SOD1']",0.9964075375310776,0,0,4
207,Computational Model of Aerobic Glycolysis WP4629,0.42274417728436275,1.4116331096196868,1.2153992591515204,"['LDHA', 'PKM', 'PFKM']",0.9964075375310776,0,0,3
208,Glycolysis in senescence WP5049,0.42274417728436275,1.4116331096196868,1.2153992591515204,"['LDHA', 'PKM', 'ALDOC']",0.9964075375310776,0,0,3
209,"GPCRs, Class B Secretin-like WP334",0.42274417728436275,1.4116331096196868,1.2153992591515204,"['ADCYAP1R1', 'ADGRL2', 'ADGRL3']",0.9964075375310776,0,0,3
210,Hedgehog Signaling Pathway Netpath WP47,0.42274417728436275,1.4116331096196868,1.2153992591515204,"['STK36', 'SAP18', 'GLI3']",0.9964075375310776,0,0,3
211,Kynurenine Pathway and links to Cellular Senescence WP5044,0.42274417728436275,1.4116331096196868,1.2153992591515204,"['QPRT', 'KMO', 'FOXO1']",0.9964075375310776,0,0,3
212,"NAD metabolism, sirtuins and aging WP3630",0.42274417728436275,1.4116331096196868,1.2153992591515204,"['PPARG', 'NFKB1', 'FOXO1']",0.9964075375310776,0,0,3
213,Osteopontin Signaling WP1434,0.42274417728436275,1.4116331096196868,1.2153992591515204,"['MAP2K1', 'SPP1', 'NFKB1']",0.9964075375310776,0,0,3
214,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.42319244766160047,1.0697197539302803,0.9198822299838456,"['RYR2', 'ADCYAP1R1', 'CEBPB', 'CHRNA4', 'YWHAB', 'ATP1A3', 'RORA', 'YBX1', 'ASCL1', 'HSP90B1', 'HSPD1', 'SOX2', 'YWHAQ', 'MAP2', 'EP300', 'PRKACA', 'NTRK2', 'MEF2C', 'JUN', 'NFKB1', 'TF', 'PRKAR1A', 'SST', 'PLP1', 'SLC25A4']",0.9964075375310776,0,0,25
215,G1 to S cell cycle control WP45,0.4245893214022327,1.1359329680953916,0.9730775297329706,"['CREB3', 'CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'RPA3', 'POLE2', 'MCM4', 'RPA2', 'MNAT1']",0.9964075375310776,0,0,10
216,Aspirin and miRNAs WP4707,0.4252080533278521,1.6468505404398062,1.408348198379803,"['PPARA', 'NFKB1']",0.9964075375310776,0,0,2
217,Biogenic Amine Synthesis WP550,0.4252080533278521,1.6468505404398062,1.408348198379803,"['GAD1', 'GAD2']",0.9964075375310776,0,0,2
218,LDLRAD4 and what we know about it WP4904,0.4252080533278521,1.6468505404398062,1.408348198379803,"['SMAD2', 'LDLRAD4']",0.9964075375310776,0,0,2
219,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.4252080533278521,1.6468505404398062,1.408348198379803,"['AHCY', 'CDO1']",0.9964075375310776,0,0,2
220,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4252080533278521,1.6468505404398062,1.408348198379803,"['TGFB1', 'IFNGR2']",0.9964075375310776,0,0,2
221,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4319383798398091,1.098090602770498,0.9218166880282747,"['SMAD2', 'MAP2K1', 'JUN', 'TGFB1', 'DCC', 'GADD45A', 'BRAF', 'MAPK10', 'MSH2', 'AKT3', 'CYCS', 'BAX', 'RAC1', 'EXOC2']",0.9964075375310776,0,0,14
222,Spinal Cord Injury WP2431,0.4319383798398091,1.098090602770498,0.9218166880282747,"['EPHA4', 'TGFB1', 'CDKN1B', 'GADD45A', 'NCAN', 'PRKCA', 'RTN4', 'CDC42', 'PPP3CA', 'COL4A1', 'APEX1', 'MBP', 'RAC1', 'SLIT2']",0.9964075375310776,0,0,14
223,Nuclear Receptors Meta-Pathway WP2882,0.4328663386942708,1.0459987397605546,0.8758422391414352,"['ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'MGST3', 'ABHD2', 'SLC2A3', 'SLC6A1', 'SLC5A3', 'FOXO1', 'SULT1A1', 'AKAP13', 'EPB41L4B', 'SLC39A6', 'EP300', 'SLC39A7', 'NCOA1', 'GSTM3', 'NCOA2', 'JUN', 'HSP90AA1', 'TGFB1', 'SLC2A13', 'SLC39A11', 'AIP', 'CES4A', 'TGFBR3', 'SLC7A5', 'KAT2B', 'PSMC5', 'NAV3', 'ACOX1', 'CDC37', 'CDC42EP3', 'BAX', 'PPARA', 'SQSTM1', 'CES2', 'SLC27A5', 'FTL']",0.9964075375310776,0,0,40
224,Integrated Cancer Pathway WP1971,0.4380656954369069,1.1457341930454272,0.9456734098078503,"['ATF1', 'SMAD2', 'CDKN1B', 'POU2F1', 'MSH2', 'STAT1', 'BAX', 'MAP3K5']",0.9964075375310776,0,0,8
225,Netrin-UNC5B signaling pathway WP4747,0.4380656954369069,1.1457341930454272,0.9456734098078503,"['MAP2K1', 'JUN', 'PIK3CA', 'DAPK1', 'PRKCA', 'FYN', 'RAC1', 'NEO1']",0.9964075375310776,0,0,8
226,p38 MAPK Signaling Pathway WP400,0.4380656954369069,1.1457341930454272,0.9456734098078503,"['CDC42', 'STAT1', 'DDIT3', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1', 'MAP3K5']",0.9964075375310776,0,0,8
227,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4380656954369069,1.1457341930454272,0.9456734098078503,"['TGFB1', 'DDX58', 'STAT1', 'EP300', 'TRIM25', 'TANK', 'NFKB1', 'IFNAR1']",0.9964075375310776,0,0,8
228,Thermogenesis WP4321,0.4437411460267366,1.0643104643104644,0.8647670365967587,"['RPS6', 'PRKAG1', 'ADCY2', 'ACSL3', 'ADCY8', 'PRKAB1', 'ARID1B', 'ACTG1', 'RPTOR', 'CREB3', 'RPS6KA6', 'SLC25A29', 'ADCY9', 'RPS6KB1', 'RPS6KA2', 'PPARG', 'PRKACA', 'HRAS', 'MGLL', 'MAP3K5', 'CREB5']",0.9964075375310776,0,0,21
229,miRNA regulation of prostate cancer signaling pathways WP3981,0.44578717448266114,1.1528566094100074,0.9314085659999002,"['MAP2K1', 'CDKN1B', 'PIK3CA', 'AKT3', 'PLCL2', 'FOXO1', 'NFKB1']",0.9964075375310776,0,0,7
230,Cardiac Hypertrophic Response WP2795,0.451895578011718,1.0979805534779357,0.8721305079823357,"['MEF2A', 'PPP3CA', 'MAP2K1', 'CAMK2D', 'TGFB1', 'PRKCA', 'RAC1', 'PRKD1', 'CALM1', 'NFKB1', 'FGFR2']",0.9964075375310776,0,0,11
231,Kit receptor signaling pathway WP304,0.451895578011718,1.0979805534779357,0.8721305079823357,"['MAP2K1', 'RPS6KB1', 'STAT1', 'RPS6', 'EP300', 'PRKCA', 'MITF', 'FYN', 'GAB2', 'MAPT', 'HRAS']",0.9964075375310776,0,0,11
232,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.451895578011718,1.0979805534779357,0.8721305079823357,"['IFI27L2', 'CAMK2D', 'JUN', 'PLCB4', 'STAT1', 'PRKCE', 'PRKCA', 'ISG15', 'PLCB1', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,11
233,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.451895578011718,1.0979805534779357,0.8721305079823357,"['RPTOR', 'NTRK2', 'PIK3CA', 'HOMER1', 'RPS6KB1', 'AKT3', 'PRKAG1', 'CACNA1C', 'HRAS', 'PRKAB1', 'GRIN2B']",0.9964075375310776,0,0,11
234,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.45443070685710985,1.1625057637836769,0.9168797316376787,"['SMAD2', 'TGFB1', 'PIK3CA', 'BAX', 'BRAF', 'MAP3K5']",0.9964075375310776,0,0,6
235,Sphingolipid pathway WP1422,0.45443070685710985,1.1625057637836769,0.9168797316376787,"['UGCG', 'ASAH1', 'CERS6', 'SERINC1', 'SGPP2', 'PLPP1']",0.9964075375310776,0,0,6
236,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4643419073924832,1.1763059701492538,0.9023844555309074,"['NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1', 'AAMP']",0.9964075375310776,0,0,5
237,Unfolded protein response WP4925,0.4643419073924832,1.1763059701492538,0.9023844555309074,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'ATF4']",0.9964075375310776,0,0,5
238,One-carbon metabolism WP241,0.4761200260978894,1.1976535214133126,0.8887610737745512,"['AHCYL2', 'ALDH1L1', 'AHCY', 'AMT']",0.9964075375310776,0,0,4
239,Striated Muscle Contraction Pathway WP383,0.4761200260978894,1.1976535214133126,0.8887610737745512,"['MYOM1', 'TPM1', 'DMD', 'ACTG1']",0.9964075375310776,0,0,4
240,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.47736272651194517,1.097870750840493,0.8118519742695743,"['GABRA2', 'NTRK2', 'GABRB1', 'ROCK1', 'PIK3CA', 'AP2B1', 'GABRD', 'GABRG3']",0.9964075375310776,0,0,8
241,NO/cGMP/PKG mediated Neuroprotection WP4008,0.47736272651194517,1.097870750840493,0.8118519742695743,"['GUCY1A2', 'CAMK2D', 'AKAP9', 'CYCS', 'CALM1', 'GRIN2B', 'NFKB1', 'PPID']",0.9964075375310776,0,0,8
242,IL-18 signaling pathway WP4754,0.48626148748385895,1.0221814347639318,0.7370017684502037,"['CEBPB', 'STOML1', 'EPB41', 'CD81', 'HSPB8', 'RGS16', 'COX17', 'ACACB', 'CENPB', 'RPTOR', 'TMSB4X', 'SPP1', 'LRRFIP1', 'B2M', 'ZBTB7A', 'ABCF1', 'MEF2A', 'JUN', 'HPS1', 'PRKCA', 'NDUFC1', 'GRIN2B', 'RUNX2', 'NFKB1', 'SLC4A7', 'ARL4D', 'TF', 'RPS6KB1', 'NACA', 'SYT10', 'CYCS', 'BAX', 'HDGF', 'PPT2', 'AARS', 'ITM2C']",0.9964075375310776,0,0,36
243,"GPCRs, Other WP117",0.48785737433484927,1.097834204630321,0.7879509386741529,"['EDNRA', 'ADGRV1', 'CELSR2', 'CELSR3', 'ADGRL2', 'GPR135', 'ADGRL3']",0.9964075375310776,0,0,7
244,BMP Signaling Pathway in Eyelid Development WP3927,0.49094709750473337,1.2350391498881432,0.8786301951771885,"['JUN', 'SFRP1', 'FGFR2']",0.9964075375310776,0,0,3
245,FOXA2 pathway WP5066,0.49094709750473337,1.2350391498881432,0.8786301951771885,"['ACACA', 'FOXO1', 'SLC27A5']",0.9964075375310776,0,0,3
246,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.49094709750473337,1.2350391498881432,0.8786301951771885,"['ZEB1', 'IL6ST', 'NFKB1']",0.9964075375310776,0,0,3
247,Overview of nanoparticle effects WP3287,0.49094709750473337,1.2350391498881432,0.8786301951771885,"['COL4A1', 'AKT3', 'BAX']",0.9964075375310776,0,0,3
248,Tryptophan catabolism leading to NAD+ production WP4210,0.49094709750473337,1.2350391498881432,0.8786301951771885,"['NMRK1', 'QPRT', 'KMO']",0.9964075375310776,0,0,3
249,DNA damage response WP707,0.49426132017508506,1.0624057883629785,0.7486677054565851,"['CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'SESN1', 'ABL1', 'TLK1', 'RPA2', 'CYCS', 'BAX']",0.9964075375310776,0,0,10
250,Melanoma WP4685,0.498715434866817,1.0442529574996349,0.7265072673345447,"['MAP2K1', 'GADD45A', 'MITF', 'BRAF', 'CDK6', 'PIK3CA', 'ERBB4', 'AKT3', 'BAX', 'CALM3', 'RAC1', 'CALM1', 'HRAS']",0.9964075375310776,0,0,13
251,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.49991206372812935,1.0977976857036207,0.7611284601222599,"['JUN', 'STAT1', 'DDX58', 'EIF2AK2', 'NFKB1', 'IFNAR1']",0.9964075375310776,0,0,6
252,The influence of laminopathies on Wnt signaling WP4844,0.49991206372812935,1.0977976857036207,0.7611284601222599,"['CEBPB', 'CDK6', 'SPP1', 'PPARG', 'EMD', 'RUNX2']",0.9964075375310776,0,0,6
253,Endoderm differentiation WP2853,0.5007801849981219,1.0236207281661827,0.7079238394571737,"['SMAD2', 'TGFB1', 'STAT1', 'CTR9', 'PBX3', 'CDYL', 'TRERF1', 'EMSY', 'FOXO1', 'ACACA', 'SOX2', 'SFRP1', 'CAND1', 'DDAH1', 'RFX7', 'SESN1', 'TCEAL2', 'UBR5', 'TCF4', 'CEBPZ', 'ASCC3', 'TOX', 'BPTF']",0.9964075375310776,0,0,23
254,Oncostatin M Signaling Pathway WP2374,0.5077616333337748,1.0399905487624785,0.7048464884235728,"['MAP2K1', 'CEBPB', 'CDKN1B', 'STAT1', 'PRKCE', 'RPS6', 'PXN', 'PRKCA', 'RICTOR', 'IL6ST', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,12
255,Dual hijack model of Vif in HIV infection WP3300,0.511691768323757,1.3173313455087587,0.8826552761141665,"['ELOB', 'ELOC']",0.9964075375310776,0,0,2
256,Glial Cell Differentiation WP2276,0.511691768323757,1.3173313455087587,0.8826552761141665,"['PLP1', 'MBP']",0.9964075375310776,0,0,2
257,HIF1A and PPARG regulation of glycolysis WP2456,0.511691768323757,1.3173313455087587,0.8826552761141665,"['LDHA', 'PPARG']",0.9964075375310776,0,0,2
258,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.511691768323757,1.3173313455087587,0.8826552761141665,"['TGFB1', 'NFKB1']",0.9964075375310776,0,0,2
259,Pentose Phosphate Metabolism WP134,0.511691768323757,1.3173313455087587,0.8826552761141665,"['TALDO1', 'TKT']",0.9964075375310776,0,0,2
260,Thiamine metabolic pathways WP4297,0.511691768323757,1.3173313455087587,0.8826552761141665,"['PDHA1', 'TKT']",0.9964075375310776,0,0,2
261,Cardiac Progenitor Differentiation WP2406,0.5141657391240697,1.0977611940298508,0.7302413021701093,"['SOX2', 'MESP1', 'MEF2C', 'TGFB1', 'THY1']",0.9964075375310776,0,0,5
262,Glycosylation and related congenital defects WP4521,0.5141657391240697,1.0977611940298508,0.7302413021701093,"['DPM2', 'DPM3', 'MPI', 'MOGS', 'MAGT1']",0.9964075375310776,0,0,5
263,NRF2-ARE regulation WP4357,0.5141657391240697,1.0977611940298508,0.7302413021701093,"['AIMP2', 'CEBPB', 'PIK3CA', 'PRKCA', 'FYN']",0.9964075375310776,0,0,5
264,G13 Signaling Pathway WP524,0.5159478012099831,1.0538363840119538,0.6973758889052513,"['CDC42', 'MAPK10', 'ROCK1', 'RPS6KB1', 'PIK3CA', 'CFL2', 'RAC1', 'CALM1']",0.9964075375310776,0,0,8
265,Phosphodiesterases in neuronal function WP4222,0.5283239912832611,1.029088785046729,0.6566055338587358,"['GRIA1', 'GUCY1A2', 'ADCY9', 'PDE10A', 'PDE4D', 'PDE5A', 'ADCY2', 'PDE6B', 'ADCY8', 'GRIN2B']",0.9964075375310776,0,0,10
266,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['CCND2', 'NFKB1', 'RUNX2', 'FGFR2']",0.9964075375310776,0,0,4
267,Immune response to tuberculosis WP4197,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['STAT1', 'IFNGR2', 'IFIT3', 'IFNAR1']",0.9964075375310776,0,0,4
268,Nucleotide metabolism WP404,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9964075375310776,0,0,4
269,Proteoglycan biosynthesis WP4784,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['B3GAT3', 'IMPAD1', 'B4GALT7', 'PAPSS2']",0.9964075375310776,0,0,4
270,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5317432177712456,1.0977247295785155,0.6933169890146391,"['PIK3CA', 'AKT3', 'BRAF', 'HRAS']",0.9964075375310776,0,0,4
271,Signal Transduction of S1P Receptor WP26,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1']",0.9964075375310776,0,0,4
272,Zinc homeostasis WP3529,0.5317432177712456,1.0977247295785155,0.6933169890146391,"['SLC30A9', 'SLC39A6', 'SLC39A11', 'SLC39A7']",0.9964075375310776,0,0,4
273,Androgen receptor signaling pathway WP138,0.5376266874959068,1.004594764637471,0.6234423179735649,"['NCOA1', 'NCOA2', 'JUN', 'ROCK1', 'DSTN', 'RUNX2', 'FOXO1', 'CDC42', 'KAT2B', 'SUMO1', 'KAT5', 'RACK1', 'EP300', 'RAC1', 'CALR', 'FKBP4', 'PLPP1', 'RAN']",0.9964075375310776,0,0,18
274,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5402065711469465,1.0219576310499459,0.629325263272243,"['BEX3', 'CDKN1B', 'HSPA5', 'RPS6KB1', 'SERBP1', 'ABL1', 'SQSTM1', 'NFKB1', 'HSPD1']",0.9964075375310776,0,0,9
275,Oxidative Damage WP3941,0.5439811400915465,1.0399009842635705,0.6331340449331562,"['CDC42', 'MAPK10', 'CDKN1B', 'GADD45A', 'CYCS', 'NFKB1']",0.9964075375310776,0,0,6
276,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5439811400915465,1.0399009842635705,0.6331340449331562,"['RPTOR', 'CDKN1B', 'PIK3CA', 'RICTOR', 'HRAS', 'FOXO1']",0.9964075375310776,0,0,6
277,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5487320413998231,1.6466095380029806,0.9882045495301762,['NFKB1'],0.9964075375310776,0,0,1
278,Estrogen metabolism WP697,0.5487320413998231,1.6466095380029806,0.9882045495301762,['SULT1A1'],0.9964075375310776,0,0,1
279,FTO Obesity Variant Mechanism WP3407,0.5487320413998231,1.6466095380029806,0.9882045495301762,['ARID5B'],0.9964075375310776,0,0,1
280,GABA metabolism (aka GHB) WP4157,0.5487320413998231,1.6466095380029806,0.9882045495301762,['ABAT'],0.9964075375310776,0,0,1
281,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.5487320413998231,1.6466095380029806,0.9882045495301762,['GSS'],0.9964075375310776,0,0,1
282,Gene regulatory network modelling somitogenesis  WP2854,0.5487320413998231,1.6466095380029806,0.9882045495301762,['EPHA4'],0.9964075375310776,0,0,1
283,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5487320413998231,1.6466095380029806,0.9882045495301762,['ABCB1'],0.9964075375310776,0,0,1
284,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5487320413998231,1.6466095380029806,0.9882045495301762,['FYN'],0.9964075375310776,0,0,1
285,Platelet-mediated interactions with vascular and circulating cells WP4462,0.5487320413998231,1.6466095380029806,0.9882045495301762,['TGFB1'],0.9964075375310776,0,0,1
286,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5487320413998231,1.6466095380029806,0.9882045495301762,['EPHA4'],0.9964075375310776,0,0,1
287,Sulindac Metabolic Pathway WP2542,0.5487320413998231,1.6466095380029806,0.9882045495301762,['MSRA'],0.9964075375310776,0,0,1
288,Tamoxifen metabolism WP691,0.5487320413998231,1.6466095380029806,0.9882045495301762,['SULT1A1'],0.9964075375310776,0,0,1
289,Vitamin B6-dependent and responsive disorders WP4228,0.5487320413998231,1.6466095380029806,0.9882045495301762,['PNPO'],0.9964075375310776,0,0,1
290,Glycogen Synthesis and Degradation WP500,0.5535140726165225,1.013189276170225,0.5992691385233236,"['PPP2R5E', 'PPP2R2B', 'PHKG2', 'PPP2R5B', 'PHKA1', 'CALM3', 'CALM1', 'PHKA2']",0.9964075375310776,0,0,8
291,GDNF/RET signaling axis WP4830,0.5548907442760035,1.0976882923191649,0.6465208870192072,"['EYA1', 'SLIT2', 'GLI3']",0.9964075375310776,0,0,3
292,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.5548907442760035,1.0976882923191649,0.6465208870192072,"['ABCB1', 'PPARG', 'PPARA']",0.9964075375310776,0,0,3
293,Omega-3/Omega-6 FA synthesis WP4723,0.5548907442760035,1.0976882923191649,0.6465208870192072,"['ACOX1', 'ACSL3', 'FADS1']",0.9964075375310776,0,0,3
294,SARS coronavirus and innate immunity WP4912,0.5548907442760035,1.0976882923191649,0.6465208870192072,"['STAT1', 'DDX58', 'IFNAR1']",0.9964075375310776,0,0,3
295,Mesodermal commitment pathway WP2857,0.5605564760629849,0.9877252252252252,0.5717203314347262,"['SMAD2', 'MACF1', 'SETD2', 'PBX3', 'ARID5B', 'TRERF1', 'EMSY', 'ACACA', 'SOX2', 'LATS1', 'CCDC88A', 'DDAH1', 'PRKAR1A', 'SESN1', 'UBR5', 'RPL38', 'TCF4', 'ASCC3', 'PRKACA', 'TOX', 'TEAD1']",0.9964075375310776,0,0,21
296,miRNA regulation of DNA damage response WP1530,0.5615782642426306,0.9977909940526763,0.5757295247357522,"['CDKN1B', 'CCND2', 'CDK6', 'GADD45A', 'SESN1', 'ABL1', 'TLK1', 'RPA2', 'CYCS', 'BAX']",0.9964075375310776,0,0,10
297,Amyotrophic lateral sclerosis (ALS) WP2447,0.5686550988800274,1.0021430658830406,0.5656909021137773,"['GRIA1', 'PPP3CA', 'CCS', 'BAX', 'RAC1', 'MAP3K5', 'SOD1']",0.9964075375310776,0,0,7
298,MAPK Cascade WP422,0.5686550988800274,1.0021430658830406,0.5656909021137773,"['MAPK10', 'MAP2K1', 'JUN', 'MAP2', 'MBP', 'BRAF', 'HRAS']",0.9964075375310776,0,0,7
299,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.5687909744672368,0.9827784156142365,0.5545251224552169,"['SMAD2', 'MAP2K1', 'SPARC', 'TGFB1', 'PDCD6', 'EIF5A2', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'CDH2', 'COL4A2', 'PIK3CA', 'RBBP4', 'COL4A1', 'ID2', 'AKT3', 'STRAP', 'HRAS', 'MEF2D']",0.9964075375310776,0,0,20
300,MECP2 and Associated Rett Syndrome WP3584,0.5751130713195418,0.9807148490086588,0.5425202858397442,"['GRIA1', 'MEF2C', 'RBFOX1', 'PRPF38A', 'GRID1', 'GAD1', 'RPS6', 'YBX1', 'IGF1R', 'FUT8', 'SST', 'MBP', 'GRIA3', 'GRIA4']",0.9964075375310776,0,0,14
301,Pathways affected in adenoid cystic carcinoma WP3651,0.5806934512116037,0.9788352301441307,0.5320285483699309,"['MAGI1', 'SETD2', 'MYCBP', 'PIK3CA', 'NFIB', 'MAGI2', 'JMJD1C', 'EP300', 'TLK1', 'ARID5B', 'HRAS']",0.9964075375310776,0,0,11
302,Regulation of toll-like receptor signaling pathway WP1449,0.5810167544158416,0.9754797885183798,0.5296618067075131,"['MAP2K1', 'JUN', 'CUEDC2', 'STAT1', 'PELI3', 'NFKB1', 'TIRAP', 'MAPK10', 'PIK3CA', 'TOLLIP', 'AKT3', 'SPP1', 'TAB2', 'RAC1', 'SQSTM1', 'IFNAR1']",0.9964075375310776,0,0,16
303,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5842564428787126,1.013169598025995,0.5444928212026595,"['SMAD2', 'TGFBR3', 'RUNX2', 'FBN1']",0.9964075375310776,0,0,4
304,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5842564428787126,1.013169598025995,0.5444928212026595,"['RAB5B', 'RAB5C', 'BRAF', 'HRAS']",0.9964075375310776,0,0,4
305,Purine metabolism and related disorders WP4224,0.5842564428787126,1.013169598025995,0.5444928212026595,"['PRPS1', 'GRM5', 'PFAS', 'ITPA']",0.9964075375310776,0,0,4
306,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5842564428787126,1.013169598025995,0.5444928212026595,"['ATF1', 'MAP2K1', 'BRAF', 'HTR4']",0.9964075375310776,0,0,4
307,Sleep regulation WP3591,0.5842564428787126,1.013169598025995,0.5444928212026595,"['NLGN1', 'AHCY', 'CRH', 'BTBD9']",0.9964075375310776,0,0,4
308,Base Excision Repair WP4752,0.5862358748017032,0.9877939529675251,0.5275146210968408,"['POLE4', 'NEIL2', 'MPG', 'APEX1', 'POLE2', 'POLD2']",0.9964075375310776,0,0,6
309,Development of ureteric collection system WP5053,0.5862358748017032,0.9877939529675251,0.5275146210968408,"['GRIP1', 'FRAS1', 'ILK', 'SLIT2', 'GLI3', 'FGFR2']",0.9964075375310776,0,0,6
310,Intraflagellar transport proteins binding to dynein WP4532,0.5862358748017032,0.9877939529675251,0.5275146210968408,"['DYNC2LI1', 'DYNC2H1', 'WDR60', 'WDR19', 'DYNLL2', 'DYNC1I1']",0.9964075375310776,0,0,6
311,Autosomal recessive Osteopetrosis pathways WP4788,0.589088390058191,1.0976518822213939,0.5808543677284751,"['OSTM1', 'NFKB1']",0.9964075375310776,0,0,2
312,Dopamine metabolism WP2436,0.589088390058191,1.0976518822213939,0.5808543677284751,"['PRKACA', 'SOD1']",0.9964075375310776,0,0,2
313,Galanin receptor pathway WP4970,0.589088390058191,1.0976518822213939,0.5808543677284751,"['CDKN1B', 'PPARG']",0.9964075375310776,0,0,2
314,Glutathione metabolism WP100,0.589088390058191,1.0976518822213939,0.5808543677284751,"['GPX4', 'GSS']",0.9964075375310776,0,0,2
315,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.589088390058191,1.0976518822213939,0.5808543677284751,"['ELOB', 'ELOC']",0.9964075375310776,0,0,2
316,Matrix Metalloproteinases WP129,0.589088390058191,1.0976518822213939,0.5808543677284751,"['MMP16', 'TIMP2']",0.9964075375310776,0,0,2
317,Mitochondrial CII Assembly WP4920,0.589088390058191,1.0976518822213939,0.5808543677284751,"['SDHAF1', 'SDHAF4']",0.9964075375310776,0,0,2
318,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.589088390058191,1.0976518822213939,0.5808543677284751,"['DDX58', 'ADAR']",0.9964075375310776,0,0,2
319,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.589088390058191,1.0976518822213939,0.5808543677284751,"['TGFB1', 'NFKB1']",0.9964075375310776,0,0,2
320,Trans-sulfuration pathway WP2333,0.589088390058191,1.0976518822213939,0.5808543677284751,"['AHCY', 'GOT1']",0.9964075375310776,0,0,2
321,PDGF Pathway WP2526,0.5898001410163228,0.9755530652056614,0.5150642576117888,"['CDC42', 'TIAM1', 'MAP2K1', 'JUN', 'STAT1', 'RAC1', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,8
322,B Cell Receptor Signaling Pathway WP23,0.5912355486621695,0.9682749504296101,0.5088679741398882,"['MEF2C', 'MAP2K1', 'JUN', 'CD81', 'GAB1', 'BRAF', 'GAB2', 'ILF2', 'FOXO1', 'NFKB1', 'CDC42', 'FYN', 'RAC1', 'HRAS', 'MEF2D']",0.9964075375310776,0,0,15
323,Corticotropin-releasing hormone signaling pathway WP2355,0.5912355486621695,0.9682749504296101,0.5088679741398882,"['NCOA2', 'HSP90AA1', 'MAP2K1', 'TGFB1', 'PRKCA', 'BRAF', 'ACACA', 'NFKB1', 'GNB2', 'GNAQ', 'GNB1', 'CRH', 'TCF4', 'GNB5', 'MAP3K5']",0.9964075375310776,0,0,15
324,Circadian rhythm related genes WP3594,0.5954771104232687,0.9680957128614157,0.5018533908029359,"['NLGN1', 'AHCY', 'BHLHE41', 'RORA', 'RORB', 'HEBP1', 'DBP', 'EP300', 'BTRC', 'RPS27A', 'SKP1', 'NCOA2', 'JUN', 'HOMER1', 'KCND2', 'USP2', 'BTBD9', 'MAPK10', 'PER1', 'PSPC1', 'ID2', 'GNAQ', 'CRY2', 'CRH', 'CRY1', 'PPARG', 'ATF5', 'PPARA', 'UBA52', 'ATF4']",0.9964075375310776,0,0,30
325,Nucleotide Excision Repair WP4753,0.6083624511419097,0.9558078981628815,0.47502165099770755,"['POLE4', 'GTF2H2C', 'RPA3', 'POLE2', 'POLD2', 'RPA2', 'GTF2H3', 'MNAT1', 'GTF2H5']",0.9964075375310776,0,0,9
326,MAPK pathway in congenital thyroid cancer WP4928,0.6137495480164593,0.9878076062639821,0.48221639573740827,"['MAP2K1', 'JUN', 'BRAF']",0.9964075375310776,0,0,3
327,TGF-beta Signaling Pathway WP366,0.6177730742803842,0.9527738798743008,0.4588883736324648,"['MEF2A', 'SMAD2', 'MEF2C', 'MAP2K1', 'JUN', 'TGFB1', 'SMURF2', 'ROCK1', 'ZFYVE9', 'WWP1', 'RUNX2', 'PJA1', 'TGFBR3', 'CDC42', 'ZEB2', 'ZEB1', 'SUMO1', 'EP300', 'STRAP', 'RAC1', 'BTRC', 'SKP1']",0.9964075375310776,0,0,22
328,Cell cycle WP179,0.6201400498882027,0.948428328208777,0.45316848215486105,"['SMAD2', 'TGFB1', 'CDKN1B', 'GADD45A', 'YWHAB', 'ANAPC10', 'STAG1', 'CCND2', 'CDC23', 'CDK6', 'STAG2', 'YWHAQ', 'CDC27', 'ABL1', 'EP300', 'MCM4', 'SKP1']",0.9964075375310776,0,0,17
329,ErbB signaling pathway WP673,0.6201400498882027,0.948428328208777,0.45316848215486105,"['MAP2K1', 'CAMK2D', 'JUN', 'CDKN1B', 'GAB1', 'PRKCA', 'BRAF', 'FOXO1', 'MAPK10', 'NRG3', 'PIK3CA', 'RPS6KB1', 'ERBB4', 'AKT3', 'NCK2', 'ABL1', 'HRAS']",0.9964075375310776,0,0,17
330,NRF2 pathway WP2884,0.6201400498882027,0.948428328208777,0.45316848215486105,"['GSTM3', 'HSP90AA1', 'TGFB1', 'HSP90AB1', 'SRXN1', 'MGST3', 'SLC2A13', 'SLC39A11', 'SLC2A3', 'SLC6A1', 'SLC5A3', 'CES4A', 'SLC39A6', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9964075375310776,0,0,17
331,IL-6 signaling pathway WP364,0.6245909968989548,0.9406051550242809,0.4427035747221212,"['NCOA1', 'MAP2K1', 'RPS6KB1', 'STAT1', 'GAB1', 'RAC1', 'VIP', 'IL6ST']",0.9964075375310776,0,0,8
332,1q21.1 copy number variation syndrome WP4905,0.633168312058702,0.9406937709809773,0.42991492309080465,"['TJP1', 'AFDN', 'PRKAG1', 'PRKAB1']",0.9964075375310776,0,0,4
333,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.633168312058702,0.9406937709809773,0.42991492309080465,"['B3GALNT1', 'UGCG', 'ST6GALNAC3', 'SGPP2']",0.9964075375310776,0,0,4
334,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.633168312058702,0.9406937709809773,0.42991492309080465,"['MAP2K1', 'GNAQ', 'ITPR1', 'HRAS']",0.9964075375310776,0,0,4
335,Trans-sulfuration and one-carbon metabolism WP2525,0.633168312058702,0.9406937709809773,0.42991492309080465,"['AHCYL2', 'AHCY', 'GSS', 'AMT']",0.9964075375310776,0,0,4
336,Apoptosis WP254,0.6399541417102623,0.9284275933490593,0.41441178817823776,"['HRK', 'MAPK10', 'JUN', 'CRADD', 'CASP6', 'CYCS', 'BAX', 'NFKB1', 'BCL2L2', 'IGF1R', 'NFKBIB']",0.9964075375310776,0,0,11
337,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6399541417102623,0.9284275933490593,0.41441178817823776,"['GHR', 'RPTOR', 'PTPRD', 'MAPK10', 'CNTFR', 'IFNGR2', 'IL3RA', 'RICTOR', 'IL6ST', 'MAPK6', 'IFNAR1']",0.9964075375310776,0,0,11
338,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6404533720821675,0.9258338004484304,0.4125320615131304,"['MAPK10', 'MAP2K1', 'TOLLIP', 'MBP', 'TAB2', 'IL1RAP', 'TANK', 'NFKB1', 'NFKBIB']",0.9964075375310776,0,0,9
339,IL17 signaling pathway WP2112,0.6496442468180009,0.9144900497512438,0.39444733930315395,"['CEBPB', 'TRAF3IP2', 'PIK3CA', 'NFKB1', 'NFKBIB']",0.9964075375310776,0,0,5
340,Cytokines and Inflammatory Response WP530,0.6538827595971942,1.0976154992548435,0.4662969304932517,['TGFB1'],0.9964075375310776,0,0,1
341,FOXP3 in COVID-19 WP5063,0.6538827595971942,1.0976154992548435,0.4662969304932517,['IL6ST'],0.9964075375310776,0,0,1
342,Hypothetical Craniofacial Development Pathway WP3655,0.6538827595971942,1.0976154992548435,0.4662969304932517,['ARHGAP29'],0.9964075375310776,0,0,1
343,LTF danger signal response pathway WP4478,0.6538827595971942,1.0976154992548435,0.4662969304932517,['NFKB1'],0.9964075375310776,0,0,1
344,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6538827595971942,1.0976154992548435,0.4662969304932517,['HIF1AN'],0.9964075375310776,0,0,1
345,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6538827595971942,1.0976154992548435,0.4662969304932517,['STRADB'],0.9964075375310776,0,0,1
346,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6538827595971942,1.0976154992548435,0.4662969304932517,['SUOX'],0.9964075375310776,0,0,1
347,Nanoparticle triggered regulated necrosis WP2513,0.6538827595971942,1.0976154992548435,0.4662969304932517,['FTL'],0.9964075375310776,0,0,1
348,PTF1A related regulatory pathway WP4147,0.6538827595971942,1.0976154992548435,0.4662969304932517,['KAT2B'],0.9964075375310776,0,0,1
349,Role of Osx and miRNAs in tooth development WP3971,0.6538827595971942,1.0976154992548435,0.4662969304932517,['RUNX2'],0.9964075375310776,0,0,1
350,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6547683553006518,0.9143302180685359,0.38719485708944335,"['GRIA1', 'ACTR2', 'MAP2K1', 'JUN', 'CDKN1B', 'ERBB4', 'TMSB4X', 'MYLK', 'PFN2', 'SOD1']",0.9964075375310776,0,0,10
351,Biotin Metabolism (including IEMs) WP5031,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['ACACB', 'ACACA']",0.9964075375310776,0,0,2
352,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['ACOX1', 'PPARA']",0.9964075375310776,0,0,2
353,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.6569373751526755,0.9407379798732762,0.3952666638591903,"['GABBR1', 'GRM5']",0.9964075375310776,0,0,2
354,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['CDK8', 'H2AFY']",0.9964075375310776,0,0,2
355,Hypertrophy Model WP516,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['ZEB1', 'WDR1']",0.9964075375310776,0,0,2
356,Purine metabolism WP4792,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['PRPS1', 'ITPA']",0.9964075375310776,0,0,2
357,RAS and bradykinin pathways in COVID-19 WP4969,0.6569373751526755,0.9407379798732762,0.3952666638591903,"['ROCK1', 'NFKB1']",0.9964075375310776,0,0,2
358,DNA Replication WP466,0.6641385629165324,0.8977908989107197,0.36743391837518596,"['RPA3', 'POLE2', 'POLD2', 'RPA2', 'MCM4', 'UBA52']",0.9964075375310776,0,0,6
359,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6671055657953063,0.8979052267642872,0.3634782996094534,"['EI24', 'SHISA5', 'BAX']",0.9964075375310776,0,0,3
360,Transcription co-factors SKI and SKIL protein partners WP4533,0.6671055657953063,0.8979052267642872,0.3634782996094534,"['LATS1', 'SATB2', 'TEAD1']",0.9964075375310776,0,0,3
361,Transcription factor regulation in adipogenesis WP3599,0.6671055657953063,0.8979052267642872,0.3634782996094534,"['CEBPB', 'PPARG', 'FOXO1']",0.9964075375310776,0,0,3
362,Urea cycle and associated pathways WP4595,0.6671055657953063,0.8979052267642872,0.3634782996094534,"['GOT1', 'MDH2', 'GOT2']",0.9964075375310776,0,0,3
363,AMP-activated protein kinase (AMPK) signaling WP1403,0.6678365380721696,0.9051140613313389,0.36540526209173985,"['RPTOR', 'PIK3CA', 'RPS6KB1', 'STRADB', 'PRKAG1', 'LEPR', 'PLCB1', 'ADIPOR1', 'PRKAB1', 'ACACB', 'ACACA']",0.9964075375310776,0,0,11
364,One-carbon metabolism and related pathways WP3940,0.6771686147478141,0.8862095708622968,0.3454754862693489,"['GPX4', 'GAD1', 'GSS', 'GAD2', 'BCAT1', 'CDO1', 'SOD1']",0.9964075375310776,0,0,7
365,Prader-Willi and Angelman Syndrome WP3998,0.6771686147478141,0.8862095708622968,0.3454754862693489,"['CCND2', 'CDK6', 'FEZ1', 'NDN', 'GABRG3', 'GABRD', 'BBS4']",0.9964075375310776,0,0,7
366,Fatty Acid Biosynthesis WP357,0.6781886460761481,0.877881387541962,0.34090749547717086,"['ECHS1', 'ACSL3', 'ACACB', 'ACACA']",0.9964075375310776,0,0,4
367,IL-7 signaling pathway WP205,0.6781886460761481,0.877881387541962,0.34090749547717086,"['MAP2K1', 'CDKN1B', 'STAT1', 'FYN']",0.9964075375310776,0,0,4
368,Signal transduction through IL1R WP4496,0.6890474172187966,0.8662608012568735,0.3226346687049241,"['JUN', 'TGFB1', 'TOLLIP', 'IL1RAP', 'NFKB1']",0.9964075375310776,0,0,5
369,Glucocorticoid Receptor Pathway WP2880,0.6890535011569109,0.8776989166977961,0.32688699018278655,"['TGFBR3', 'EPB41L4B', 'AKAP13', 'HSP90AA1', 'JUN', 'NAV3', 'ABHD2', 'CDC42EP3']",0.9964075375310776,0,0,8
370,CAMKK2  Pathway WP4874,0.6994102379906247,0.858659136277326,0.30698593927238393,"['RPTOR', 'MAP1LC3A', 'EP300', 'RAC1', 'CALM1', 'SQSTM1']",0.9964075375310776,0,0,6
371,Hedgehog Signaling Pathway WP4249,0.6994102379906247,0.858659136277326,0.30698593927238393,"['CCND2', 'SMURF2', 'HHIP', 'FBXL17', 'PRKACA', 'GLI3']",0.9964075375310776,0,0,6
372,IL-5 signaling pathway WP127,0.6994102379906247,0.858659136277326,0.30698593927238393,"['MAP2K1', 'JUN', 'RPS6KB1', 'STAT1', 'RPS6', 'MAPT']",0.9964075375310776,0,0,6
373,EGF/EGFR signaling pathway WP437,0.7072996487608355,0.908433734939759,0.31459139413853693,"['ATF1', 'NDUFA13', 'ROCK1', 'STXBP1', 'PEBP1', 'NEDD8', 'FOXO1', 'CDC42', 'ATXN2', 'RPS6KA2', 'ABL1', 'NCK2', 'RICTOR', 'RAC1', 'HRAS', 'MEF2D', 'AP2M1', 'MEF2A', 'RALBP1', 'MEF2C', 'MAP2K1', 'JUN', 'STAT1', 'GAB1', 'PRKCA', 'BRAF', 'GAB2', 'AP2B1', 'RPS6KB1']",0.9964075375310776,0,0,29
374,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.7148518999086314,0.822986577181208,0.27626004430707135,"['MAP2K1', 'MAP3K11', 'MAP3K5']",0.9964075375310776,0,0,3
375,Toll-like Receptor Signaling related to MyD88 WP3858,0.7148518999086314,0.822986577181208,0.27626004430707135,"['TOLLIP', 'NFKB1', 'TIRAP']",0.9964075375310776,0,0,3
376,Canonical and non-canonical TGF-B signaling WP3874,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['SMAD2', 'TGFB1']",0.9964075375310776,0,0,2
377,Differentiation of white and brown adipocyte WP2895,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['CEBPB', 'PPARG']",0.9964075375310776,0,0,2
378,Fatty acid transporters WP5061,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['FABP5', 'ACSL3']",0.9964075375310776,0,0,2
379,Ganglio Sphingolipid Metabolism WP1423,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['ST8SIA1', 'ST3GAL5']",0.9964075375310776,0,0,2
380,Glycosaminoglycan degradation WP4815,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['HPSE2', 'ARSB']",0.9964075375310776,0,0,2
381,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7154856098334106,0.8230525531121878,0.2755528854615345,"['IDI1', 'PMVK']",0.9964075375310776,0,0,2
382,ATM Signaling Network in Development and Disease  WP3878,0.7185145769780018,0.8492896477761577,0.28074907213221634,"['DCLRE1C', 'KAT5', 'ATMIN', 'RBBP8', 'PPM1D', 'NFKB1', 'HMGN1', 'MAP3K5']",0.9964075375310776,0,0,8
383,Histone Modifications WP2369,0.7185145769780018,0.8492896477761577,0.28074907213221634,"['KMT2E', 'SETD2', 'SET', 'SETDB1', 'H3F3B', 'EHMT1', 'SMYD3', 'HIST1H4C']",0.9964075375310776,0,0,8
384,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7185145769780018,0.8492896477761577,0.28074907213221634,"['SMAD2', 'KAT2B', 'CEBPB', 'TGFB1', 'SPP1', 'PPARG', 'EMD', 'RUNX2']",0.9964075375310776,0,0,8
385,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7191943300924237,0.8229205520328235,0.27125410028655433,"['SMAD2', 'TGFBR3', 'TGFB1', 'HRAS']",0.9964075375310776,0,0,4
386,Folate Metabolism WP176,0.7191943300924237,0.8229205520328235,0.27125410028655433,"['AHCY', 'GPX4', 'NFKB1', 'SOD1']",0.9964075375310776,0,0,4
387,Sphingolipid Metabolism (general overview) WP4725,0.7191943300924237,0.8229205520328235,0.27125410028655433,"['UGCG', 'ASAH1', 'CERS6', 'SGPP2']",0.9964075375310776,0,0,4
388,Bladder cancer WP2828,0.7253139491132209,0.8228544776119403,0.2642602788109956,"['MAP2K1', 'DAPK1', 'DAPK2', 'BRAF', 'HRAS']",0.9964075375310776,0,0,5
389,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.732098989197517,0.8227883538633819,0.25657794427059233,"['MAPK10', 'MAP2K1', 'JUN', 'RPS6KA2', 'DDIT3', 'MAP3K11']",0.9964075375310776,0,0,6
390,22q11.2 copy number variation syndrome WP4657,0.7324338773229817,0.8657599053814311,0.26958223442604334,"['PRKN', 'RANBP1', 'CBX5', 'EMC10', 'ZDHHC8', 'RTN4', 'CDC42', 'MRPL40', 'XPO1', 'RELN', 'POLR2A', 'HIST1H4C', 'KPNB1', 'FGFR2', 'RAN']",0.9964075375310776,0,0,15
391,Acetylcholine Synthesis WP528,0.7345390497507231,0.8231184798807749,0.2539420269940283,['PDHA1'],0.9964075375310776,0,0,1
392,Farnesoid X receptor pathway WP2879,0.7345390497507231,0.8231184798807749,0.2539420269940283,['SLC27A5'],0.9964075375310776,0,0,1
393,Irinotecan pathway WP229,0.7345390497507231,0.8231184798807749,0.2539420269940283,['CES2'],0.9964075375310776,0,0,1
394,Ketogenesis and Ketolysis WP4742,0.7345390497507231,0.8231184798807749,0.2539420269940283,['SLC16A1'],0.9964075375310776,0,0,1
395,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.7345390497507231,0.8231184798807749,0.2539420269940283,['FADS1'],0.9964075375310776,0,0,1
396,miRNA Biogenesis WP2338,0.7345390497507231,0.8231184798807749,0.2539420269940283,['RAN'],0.9964075375310776,0,0,1
397,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7345390497507231,0.8231184798807749,0.2539420269940283,['CTSL'],0.9964075375310776,0,0,1
398,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7370623140161061,0.8554116766467066,0.26097142322137035,"['MAP2K1', 'CAMK2D', 'TGFB1', 'ROCK1', 'NFKB1', 'IGF1R', 'MYLK', 'PPP3CA', 'PIK3CA', 'RAC1', 'IL6ST', 'CALM1', 'FGFR2']",0.9964075375310776,0,0,13
399,Glioblastoma signaling pathways WP2261,0.74504121884171,0.852905694912434,0.25102356633779366,"['MAP2K1', 'CDKN1B', 'GAB1', 'PRKCA', 'BRAF', 'FOXO1', 'IGF1R', 'CCND2', 'CDK6', 'PIK3CA', 'AKT3', 'EP300', 'HRAS', 'FGFR2']",0.9964075375310776,0,0,14
400,Cannabinoid receptor signaling WP3869,0.7561954937175174,0.7744256971718191,0.2164174016637735,"['MAPK10', 'DAGLA', 'PRKAR1A', 'PRKACA']",0.9964075375310776,0,0,4
401,Lung fibrosis WP3624,0.7561954937175174,0.7744256971718191,0.2164174016637735,"['CEBPB', 'TGFB1', 'FAM13A', 'SPP1']",0.9964075375310776,0,0,4
402,Sphingolipid Metabolism (integrated pathway) WP4726,0.7561954937175174,0.7744256971718191,0.2164174016637735,"['UGCG', 'ASAH1', 'CERS6', 'SGPP2']",0.9964075375310776,0,0,4
403,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7571076966772751,0.7595938736878334,0.2113568190718785,"['H3F3B', 'H2AFY', 'H2AFZ']",0.9964075375310776,0,0,3
404,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7571076966772751,0.7595938736878334,0.2113568190718785,"['TTC9', 'CEBPB', 'ERBB4']",0.9964075375310776,0,0,3
405,Ovarian infertility WP34,0.7571076966772751,0.7595938736878334,0.2113568190718785,"['CEBPB', 'CDKN1B', 'CCND2']",0.9964075375310776,0,0,3
406,Prostaglandin Synthesis and Regulation WP98,0.7571076966772751,0.7595938736878334,0.2113568190718785,"['EDNRA', 'MITF', 'PPARG']",0.9964075375310776,0,0,3
407,Complement system WP2806,0.7584277374625709,0.7835820895522388,0.2166665244807876,"['RPS19', 'SPP1', 'PRKCA', 'CALR', 'PRKACA']",0.9964075375310776,0,0,5
408,Nanoparticle-mediated activation of receptor signaling WP2643,0.7584277374625709,0.7835820895522388,0.2166665244807876,"['MAPK10', 'MAP2K1', 'PXN', 'AKT3', 'HRAS']",0.9964075375310776,0,0,5
409,DNA Repair Pathways Full Network WP4946,0.7597503959972969,0.8632742117117117,0.23719782017801005,"['XRCC6', 'DCLRE1C', 'GTF2H2C', 'MPG', 'XRCC5', 'MGMT', 'REV1', 'RPA2', 'FANCC', 'GTF2H3', 'GTF2H5', 'POLE4', 'NEIL2', 'MSH2', 'RPA3', 'POLE2', 'APEX1', 'POLD2', 'REV3L', 'USP1', 'MNAT1']",0.9964075375310776,0,0,21
410,Signaling of Hepatocyte Growth Factor Receptor WP313,0.76218423576373,0.7897872340425532,0.2144801287014013,"['MAP2K1', 'JUN', 'PIK3CA', 'PXN', 'GAB1', 'HRAS']",0.9964075375310776,0,0,6
411,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7653829896134018,0.7315194434091191,0.19559288635759264,"['NFKB1', 'BCL2L2']",0.9964075375310776,0,0,2
412,Serotonin and anxiety WP3947,0.7653829896134018,0.7315194434091191,0.19559288635759264,"['PPP3CA', 'CRH']",0.9964075375310776,0,0,2
413,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7653829896134018,0.7315194434091191,0.19559288635759264,"['ITPR1', 'NFKB1']",0.9964075375310776,0,0,2
414,TYROBP causal network in microglia WP3945,0.7653829896134018,0.7315194434091191,0.19559288635759264,"['DPYD', 'SPP1']",0.9964075375310776,0,0,2
415,Integrin-mediated Cell Adhesion WP185,0.7717650420326102,0.8362216720624643,0.216644234200418,"['MAP2K1', 'ITGB5', 'ROCK1', 'PXN', 'ILK', 'BRAF', 'CDC42', 'MAPK10', 'AKT3', 'SELENOP', 'FYN', 'RAC1', 'MAPK6', 'HRAS', 'TNS1']",0.9964075375310776,0,0,15
416,Focal Adhesion WP306,0.7752150263151948,0.8684074108265103,0.2211094094483488,"['ITGB5', 'ROCK1', 'PXN', 'ILK', 'MYLK', 'MYL12B', 'ACTG1', 'IGF1R', 'CDC42', 'RELN', 'CCND2', 'AKT3', 'SPP1', 'FYN', 'RAC1', 'HRAS', 'JUN', 'MAP2K1', 'PPP1R12A', 'PRKCA', 'PARVA', 'BRAF', 'VEGFD', 'MAPK10', 'COL4A2', 'PIK3CA', 'COL4A1', 'COL5A2']",0.9964075375310776,0,0,28
417,Oxysterols derived from cholesterol WP4545,0.7893041026524231,0.731319159517593,0.17303274914132788,"['EBP', 'DBP', 'NR1H2', 'SLC27A5']",0.9964075375310776,0,0,4
418,PPAR signaling pathway WP3942,0.7921540268685804,0.7676997759522032,0.17887360844746977,"['FABP5', 'ACOX1', 'ILK', 'PPARG', 'ACSL3', 'PPARA', 'SLC27A5']",0.9964075375310776,0,0,7
419,7-oxo-C and 7beta-HC pathways WP5064,0.7941471964906756,0.7052572706935123,0.16255224388901762,"['EBP', 'DBP', 'SLC27A5']",0.9964075375310776,0,0,3
420,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7941471964906756,0.7052572706935123,0.16255224388901762,"['CBX5', 'RBBP4', 'H3F3B']",0.9964075375310776,0,0,3
421,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7941471964906756,0.7052572706935123,0.16255224388901762,"['PIK3CA', 'NFKB1', 'TIRAP']",0.9964075375310776,0,0,3
422,Mitochondrial Gene Expression WP391,0.7941471964906756,0.7052572706935123,0.16255224388901762,"['ESRRA', 'PPP3CA', 'HCFC1']",0.9964075375310776,0,0,3
423,TLR4 Signaling and Tolerance WP3851,0.7941471964906756,0.7052572706935123,0.16255224388901762,"['TAB2', 'NFKB1', 'TIRAP']",0.9964075375310776,0,0,3
424,Biomarkers for urea cycle disorders WP4583,0.796405149780647,0.6584202682563338,0.14988755715040666,['GOT1'],0.9964075375310776,0,0,1
425,"Degradation pathway of sphingolipids, including diseases WP4153",0.796405149780647,0.6584202682563338,0.14988755715040666,['NEU1'],0.9964075375310776,0,0,1
426,Disorders of Folate Metabolism and Transport WP4259,0.796405149780647,0.6584202682563338,0.14988755715040666,['ALDH1L1'],0.9964075375310776,0,0,1
427,Methylation Pathways WP704,0.796405149780647,0.6584202682563338,0.14988755715040666,['NNMT'],0.9964075375310776,0,0,1
428,Pilocytic astrocytoma WP2253,0.796405149780647,0.6584202682563338,0.14988755715040666,['BRAF'],0.9964075375310776,0,0,1
429,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.796405149780647,0.6584202682563338,0.14988755715040666,['NFKB1'],0.9964075375310776,0,0,1
430,Type III interferon signaling WP2113,0.796405149780647,0.6584202682563338,0.14988755715040666,['STAT1'],0.9964075375310776,0,0,1
431,Valproic acid pathway WP3871,0.796405149780647,0.6584202682563338,0.14988755715040666,['ABAT'],0.9964075375310776,0,0,1
432,ERK Pathway in Huntington's Disease WP3853,0.8074813697188935,0.6582929556466642,0.14076626883255774,"['NTRK2', 'HRAS']",0.9964075375310776,0,0,2
433,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8074813697188935,0.6582929556466642,0.14076626883255774,"['TGFB1', 'CDC37']",0.9964075375310776,0,0,2
434,Insulin Signaling WP481,0.8095033224168969,0.8451467268623025,0.17860857777728184,"['ARF1', 'STXBP4', 'STXBP1', 'FOXO1', 'IGF1R', 'RPS6KA6', 'RPS6KA2', 'RAC1', 'MAP4K5', 'MAPK6', 'HRAS', 'MAP4K3', 'MAP3K5', 'MAP4K4', 'MAP2K1', 'XBP1', 'JUN', 'GAB1', 'PRKCA', 'INPP4A', 'EHD1', 'MAPK10', 'TBC1D4', 'PIK3CA', 'RPS6KB1', 'PFKM', 'MAP3K11']",0.9964075375310776,0,0,27
435,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8108379272528499,0.7893153759820426,0.1655092426476103,"['IDI1', 'CDK8', 'SEC24B', 'PIK3CA', 'NR1H2', 'PRKAG1', 'PPARG', 'PRKACA', 'PRKAB1', 'SEC23B', 'KPNB1', 'ACACA']",0.9964075375310776,0,0,12
436,Male infertility WP4673,0.8149166206661673,0.7916874584165003,0.1620342579871189,"['PACRG', 'CCNT2', 'ABCB1', 'UBE2B', 'XRCC5', 'PON2', 'TEX15', 'CHD2', 'CDC42BPA', 'PUM2', 'ABLIM1', 'EP300', 'SOX5']",0.9964075375310776,0,0,13
437,ATM Signaling Pathway WP2516,0.8154646556037594,0.7152822842310188,0.1459155822115285,"['JUN', 'CRADD', 'GADD45A', 'ABL1', 'TLK1']",0.9964075375310776,0,0,5
438,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8154646556037594,0.7152822842310188,0.1459155822115285,"['PPP3CA', 'SUPT4H1', 'EP300', 'SUPT5H', 'NFKB1']",0.9964075375310776,0,0,5
439,Tumor suppressor activity of SMARCB1 WP4204,0.8154646556037594,0.7152822842310188,0.1459155822115285,"['CDK6', 'RBBP4', 'H3F3B', 'ARID1B', 'GLI3']",0.9964075375310776,0,0,5
440,Metapathway biotransformation Phase I and II WP702,0.818979162197025,0.7937231309466943,0.15850384109865126,"['GSTM3', 'NAA30', 'NNMT', 'GPX4', 'GSTO1', 'NAA20', 'MGST3', 'GSS', 'KCNAB1', 'NAT14', 'NDST2', 'SULT1A1', 'CYP4Z1', 'SULT4A1']",0.9964075375310776,0,0,14
441,IL-1 signaling pathway WP195,0.8194079991531846,0.7590548464987927,0.15118334609721507,"['MAP2K1', 'JUN', 'TOLLIP', 'UBE2N', 'TAB2', 'IL1RAP', 'SQSTM1', 'NFKB1', 'NFKBIB']",0.9964075375310776,0,0,9
442,Retinoblastoma gene in cancer WP2446,0.8250656942980007,0.7696971625901112,0.14800681180961692,"['ANLN', 'RABIF', 'CDKN1B', 'CDK6', 'RBBP4', 'H2AFZ', 'RPA3', 'POLE2', 'ABL1', 'MCM4', 'RPA2']",0.9964075375310776,0,0,11
443,Fluoropyrimidine Activity WP1601,0.8263429176974586,0.658165548098434,0.12554207510129117,"['DPYD', 'UMPS', 'CES2']",0.9964075375310776,0,0,3
444,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8263429176974586,0.658165548098434,0.12554207510129117,"['GOT1', 'MDH2', 'GOT2']",0.9964075375310776,0,0,3
445,Oxidation by Cytochrome P450 WP43,0.8263429176974586,0.658165548098434,0.12554207510129117,"['CYB5B', 'CYP4Z1', 'CYB5R3']",0.9964075375310776,0,0,3
446,IL-4 signaling pathway WP395,0.8366360135503581,0.7195551717699776,0.12834430252899207,"['CEBPB', 'PIK3CA', 'RPS6KB1', 'STAT1', 'EP300', 'GAB2', 'NFKB1']",0.9964075375310776,0,0,7
447,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8366360135503581,0.7195551717699776,0.12834430252899207,"['MAPK10', 'DDX58', 'TRIM25', 'ISG15', 'TANK', 'NFKB1', 'NFKBIB']",0.9964075375310776,0,0,7
448,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8396426177471433,0.6854011194029851,0.11979367614763466,"['JUN', 'TGFB1', 'COL4A2', 'RAC1', 'NFKB1']",0.9964075375310776,0,0,5
449,MET in type 1 papillary renal cell carcinoma WP4205,0.8399525971413512,0.7474086661002549,0.1303554114529189,"['CDC42', 'MAP2K1', 'JUN', 'PIK3CA', 'AKT3', 'RPL11', 'GAB1', 'BRAF', 'RAC1', 'HRAS']",0.9964075375310776,0,0,10
450,IL-9 signaling pathway WP22,0.8427052675287059,0.5983803747501101,0.1024056238337437,"['MAP2K1', 'STAT1']",0.9964075375310776,0,0,2
451,Kallmann's Syndrome WP5074,0.8427052675287059,0.5983803747501101,0.1024056238337437,"['PIK3CA', 'ASCL1']",0.9964075375310776,0,0,2
452,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8427052675287059,0.5983803747501101,0.1024056238337437,"['ROCK1', 'FGFR2']",0.9964075375310776,0,0,2
453,Omega-9 FA synthesis WP4724,0.8427052675287059,0.5983803747501101,0.1024056238337437,"['ACSL3', 'FADS1']",0.9964075375310776,0,0,2
454,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8427052675287059,0.5983803747501101,0.1024056238337437,"['BAX', 'BCL2L2']",0.9964075375310776,0,0,2
455,Canonical NF-KB pathway WP4562,0.8438572813699089,0.5486214605067065,0.09314050585898898,['NFKB1'],0.9964075375310776,0,0,1
456,"Cerebral organic acidurias, including diseases WP4519",0.8438572813699089,0.5486214605067065,0.09314050585898898,['MDH2'],0.9964075375310776,0,0,1
457,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.8438572813699089,0.5486214605067065,0.09314050585898898,['EBP'],0.9964075375310776,0,0,1
458,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.8438572813699089,0.5486214605067065,0.09314050585898898,['STAT1'],0.9964075375310776,0,0,1
459,Mevalonate pathway WP3963,0.8438572813699089,0.5486214605067065,0.09314050585898898,['PMVK'],0.9964075375310776,0,0,1
460,Neuroinflammation WP4919,0.8438572813699089,0.5486214605067065,0.09314050585898898,['JUN'],0.9964075375310776,0,0,1
461,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.8438572813699089,0.5486214605067065,0.09314050585898898,['STAG1'],0.9964075375310776,0,0,1
462,Supression of HMGB1 mediated inflammation by THBD WP4479,0.8438572813699089,0.5486214605067065,0.09314050585898898,['NFKB1'],0.9964075375310776,0,0,1
463,Small cell lung cancer WP4658,0.8443237755447622,0.7587844254510921,0.12840092200485867,"['CDKN1B', 'CDK6', 'PIK3CA', 'COL4A2', 'COL4A1', 'GADD45A', 'AKT3', 'CYCS', 'BAX', 'NFKB1', 'SKP1', 'NFKBIB']",0.9964075375310776,0,0,12
464,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.846810875367193,0.7632391467065869,0.1269098001495706,"['MAP2K1', 'RPS6', 'GAB1', 'PRKCA', 'BRAF', 'IGF1R', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'EIF4E2', 'HRAS', 'FGFR2']",0.9964075375310776,0,0,13
465,Angiogenesis WP1539,0.8541217873430713,0.6169602908277405,0.09728321622023767,"['PIK3CA', 'TIMP2', 'FGFR2']",0.9964075375310776,0,0,3
466,Gastric Cancer Network 2 WP2363,0.8541217873430713,0.6169602908277405,0.09728321622023767,"['AHCTF1', 'DSCC1', 'CEBPZ']",0.9964075375310776,0,0,3
467,Endometrial cancer WP4155,0.8555253487323256,0.7218637208793612,0.1126392943370997,"['MAP2K1', 'PIK3CA', 'GADD45A', 'AKT3', 'ILK', 'BAX', 'BRAF', 'HRAS', 'FGFR2']",0.9964075375310776,0,0,9
468,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8555253487323256,0.7218637208793612,0.1126392943370997,"['PIK3CA', 'MSH2', 'PXN', 'BAX', 'RAC1', 'HRAS', 'ANGPTL1', 'FOXO1', 'NFKB1']",0.9964075375310776,0,0,9
469,Wnt signaling pathway and pluripotency WP399,0.8592563281175832,0.7443830336912098,0.11291397255778954,"['SOX2', 'MAPK10', 'JUN', 'CCND2', 'PPP2R5E', 'PPP2R2B', 'PRKCE', 'EP300', 'PRKCA', 'PRKD1', 'FBXW2', 'PAFAH1B1']",0.9964075375310776,0,0,12
470,Microglia Pathogen Phagocytosis Pathway WP3937,0.8719718145047731,0.5484532240029817,0.07513709263214628,"['PIK3CA', 'RAC1']",0.9964075375310776,0,0,2
471,Triacylglyceride synthesis WP325,0.8719718145047731,0.5484532240029817,0.07513709263214628,"['AGPAT1', 'PLPP1']",0.9964075375310776,0,0,2
472,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8758041430358785,0.6577827547592385,0.08723040898848657,"['MAP2K1', 'JUN', 'PIK3CA', 'FYN', 'CALM1', 'NFKB1']",0.9964075375310776,0,0,6
473,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8779324587282852,0.580602710883011,0.07558612074519609,"['MAP2K1', 'THRA', 'STAT1']",0.9964075375310776,0,0,3
474,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8801833874799599,0.6325344431687715,0.08072720727046864,"['JUN', 'CASP6', 'CYCS', 'SPTAN1', 'ACTG1']",0.9964075375310776,0,0,5
475,Cancer immunotherapy by CTLA4 blockade WP4582,0.8802527398617478,0.470193740685544,0.05997142881755116,['PIK3CA'],0.9964075375310776,0,0,1
476,Homologous recombination WP186,0.8802527398617478,0.470193740685544,0.05997142881755116,['POLD2'],0.9964075375310776,0,0,1
477,ID signaling pathway WP53,0.8802527398617478,0.470193740685544,0.05997142881755116,['ID2'],0.9964075375310776,0,0,1
478,Non-small cell lung cancer WP4255,0.8851903448947508,0.699463113939153,0.08530133004699997,"['MAP2K1', 'CDK6', 'PIK3CA', 'GADD45A', 'AKT3', 'CYCS', 'BAX', 'PRKCA', 'BRAF', 'HRAS']",0.9964075375310776,0,0,10
479,ESC Pluripotency Pathways WP3931,0.8864825547762104,0.7241829899522988,0.08725958383630712,"['ACTR2', 'MAP2K1', 'JUN', 'GAB1', 'BRAF', 'FGF14', 'AKT3', 'SELENOP', 'IL6ST', 'MAPK6', 'FGF12', 'HRAS', 'FGFR2']",0.9964075375310776,0,0,13
480,Alpha 6 Beta 4 signaling pathway WP244,0.8871730688010454,0.5980807704045302,0.07159935825599753,"['GAB1', 'PRKCA', 'RAC1', 'HRAS']",0.9964075375310776,0,0,4
481,DNA damage response (only ATM dependent) WP710,0.8874804039936784,0.730313240983402,0.08717664286708905,"['JUN', 'TGFB1', 'CDKN1B', 'NFKB1', 'CDC42', 'MAPK10', 'CCND2', 'PIK3CA', 'PPP2R5E', 'AKT3', 'ABL1', 'BAX', 'RAC1', 'HRAS']",0.9964075375310776,0,0,14
482,Hippo-Merlin Signaling Dysregulation WP4541,0.8874804039936784,0.730313240983402,0.08717664286708905,"['NTRK2', 'PPP1R14A', 'PPP1R12A', 'ITGB5', 'IGF1R', 'LATS1', 'PLCB4', 'CDH2', 'PRKAR1A', 'PRKACA', 'HRAS', 'TEAD1', 'FGFR2', 'CDH18']",0.9964075375310776,0,0,14
483,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8887571881481028,0.6576549663928305,0.07755804592753875,"['IDI1', 'EBP', 'NR1H2', 'PMVK', 'ACSL3', 'FADS1', 'TM7SF2']",0.9964075375310776,0,0,7
484,Integrated breast cancer pathway WP1984,0.8906962962410626,0.7687458553383243,0.08898369098274993,"['ATF1', 'SMAD2', 'JUN', 'RALGAPA1', 'GADD45A', 'STAT1', 'ZMYND8', 'MYCBP2', 'ODC1', 'BRAF', 'PHB', 'FOXO1', 'NFKB1', 'CDC42', 'FER', 'MSH2', 'ABL1', 'EP300', 'BAX', 'RAC1', 'FAU', 'RPP38']",0.9964075375310776,0,0,22
485,MAPK Signaling Pathway WP382,0.8951522420687354,0.8033513656155166,0.08898038003223158,"['CACNA1C', 'DUSP16', 'CDC42', 'PPP3CA', 'AKT3', 'RAC1', 'PRKACA', 'CACNG2', 'HRAS', 'MAP4K3', 'CACNG4', 'MAP4K4', 'MAP3K5', 'NTRK2', 'MEF2C', 'JUN', 'MAP2K1', 'TGFB1', 'GADD45A', 'PLA2G4C', 'PRKCA', 'BRAF', 'NFKB1', 'MAPK10', 'CACNB4', 'FGF14', 'DDIT3', 'TAOK1', 'RAPGEF2', 'TAB2', 'MAPT', 'FGF12', 'MAP3K11', 'FGFR2', 'ATF4']",0.9964075375310776,0,0,35
486,Cholesterol Biosynthesis Pathway WP197,0.8961440394873273,0.5062071733707961,0.05550770242273389,"['IDI1', 'PMVK']",0.9964075375310776,0,0,2
487,Ebstein-Barr virus LMP1 signaling WP262,0.8961440394873273,0.5062071733707961,0.05550770242273389,"['HSP90AA1', 'NFKB1']",0.9964075375310776,0,0,2
488,miRNAs involvement in the immune response in sepsis WP4329,0.8961440394873273,0.5062071733707961,0.05550770242273389,"['TAB2', 'NFKB1']",0.9964075375310776,0,0,2
489,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8961440394873273,0.5062071733707961,0.05550770242273389,"['JUN', 'SRXN1']",0.9964075375310776,0,0,2
490,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8961529778981542,0.7551271268680857,0.08279526918800381,"['MAP2K1', 'THRA', 'PRKAG1', 'PRKAB1', 'FOXO1', 'RPTOR', 'SLCO1C1', 'MAPK10', 'RPS6KA6', 'PIK3CA', 'RPS6KB1', 'RPS6KA2', 'RICTOR', 'MAP4K5', 'MAPK6', 'HRAS', 'MAP3K11', 'MAP4K3', 'MAP3K5', 'MAP4K4']",0.9964075375310776,0,0,20
491,Neural Crest Differentiation WP2064,0.9002120622884534,0.657527082555099,0.0691224810624834,"['CDH2', 'MITF', 'MBP', 'TCF4', 'ASCL1', 'NFKB1', 'FGFR2', 'SOX5']",0.9964075375310776,0,0,8
492,DNA IR-double strand breaks and cellular response via ATM WP3959,0.902687674331149,0.6393141647996017,0.06545212814807753,"['LATS1', 'UPF1', 'DCLRE1C', 'KAT5', 'ABL1', 'BAX', 'MCPH1']",0.9964075375310776,0,0,7
493,15q11.2 copy number variation syndrome WP4940,0.9081670649540067,0.4113729508196721,0.03962629140747509,['TUBGCP4'],0.9964075375310776,0,0,1
494,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.9081670649540067,0.4113729508196721,0.03962629140747509,['MAP2K1'],0.9964075375310776,0,0,1
495,GPR40 Pathway WP3958,0.9081670649540067,0.4113729508196721,0.03962629140747509,['PLCB1'],0.9964075375310776,0,0,1
496,Iron metabolism in placenta WP2007,0.9081670649540067,0.4113729508196721,0.03962629140747509,['TF'],0.9964075375310776,0,0,1
497,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.9081670649540067,0.4113729508196721,0.03962629140747509,['JUN'],0.9964075375310776,0,0,1
498,Ciliopathies WP4803,0.9151008061885537,0.7640402428582549,0.06778645188349781,"['IFT172', 'CCDC28B', 'GLI3', 'DYNC2LI1', 'TBC1D32', 'TCTN3', 'CSPP1', 'TTC21B', 'NEK1', 'BBS9', 'RAB28', 'CEP290', 'BBS4', 'CEP78', 'DYNC2H1', 'WDR19', 'POMGNT1', 'TTLL5', 'TMEM138', 'WDR60', 'NME7', 'KIAA0586', 'NME9', 'SPAG1', 'CEP41', 'KIZ', 'TRIM32']",0.9964075375310776,0,0,27
499,Notch Signaling Pathway Netpath WP61,0.9151015329357736,0.6219647578870879,0.055180871862068104,"['NUMBL', 'NUMB', 'EP300', 'CIR1', 'MAPT', 'NFKB1', 'SKP1']",0.9964075375310776,0,0,7
500,MTHFR deficiency WP4288,0.9154193875283637,0.5193688920287295,0.045898172391918325,"['MARS', 'EHMT1', 'CYCS']",0.9964075375310776,0,0,3
501,Monoamine Transport WP727,0.9160063055866622,0.46999627282892287,0.04123372734434257,"['AMPH', 'SLC6A1']",0.9964075375310776,0,0,2
502,Autophagy WP4923,0.9191567237078796,0.5481163744871317,0.046205461611236794,"['RPTOR', 'MAP1LC3B', 'PRKAG1', 'PRKAB1']",0.9964075375310776,0,0,4
503,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9191567237078796,0.5481163744871317,0.046205461611236794,"['JUN', 'RAC1', 'NFKB1', 'NFKBIB']",0.9964075375310776,0,0,4
504,"GPCRs, Class A Rhodopsin-like WP455",0.9231159072271296,0.6260739633918565,0.050086214917225806,"['OPRD1', 'EDNRA', 'P2RY14', 'NPY1R', 'RRH', 'NMBR', 'HTR4', 'HTR5A']",0.9964075375310776,0,0,8
505,Joubert Syndrome WP4656,0.9273863835511078,0.6571428571428571,0.04953870740082984,"['KAT5', 'TCTN3', 'TMEM138', 'KIAA0586', 'CSPP1', 'BBS9', 'PDE6B', 'CEP41', 'CEP290', 'BBS4', 'ATF4']",0.9964075375310776,0,0,11
506,Regulation of Actin Cytoskeleton WP51,0.9277401621110611,0.7216048491845866,0.05412294929121652,"['CYFIP2', 'NCKAP1', 'MAP2K1', 'PPP1R12A', 'ROCK1', 'PXN', 'BRK1', 'BRAF', 'SSH2', 'MYLK', 'ACTG1', 'CDC42', 'FGF14', 'PIK3CA', 'CFL2', 'TMSB4X', 'RAC1', 'MAPK6', 'FGF12', 'FGFR2']",0.9964075375310776,0,0,20
507,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.9295760225760936,0.36562344759066073,0.026700268879596305,['RUNX2'],0.9964075375310776,0,0,1
508,Mammalian disorder of sexual development WP4842,0.9295760225760936,0.36562344759066073,0.026700268879596305,['FGFR2'],0.9964075375310776,0,0,1
509,NO metabolism in cystic fibrosis WP4947,0.9295760225760936,0.36562344759066073,0.026700268879596305,['DDAH1'],0.9964075375310776,0,0,1
510,PPAR-alpha pathway WP2878,0.9295760225760936,0.36562344759066073,0.026700268879596305,['PPARA'],0.9964075375310776,0,0,1
511,Neovascularisation processes WP4331,0.9299263212207806,0.49334451901565995,0.03584144006934063,"['SMAD2', 'TGFB1', 'NFKB1']",0.9964075375310776,0,0,3
512,Phosphoinositides metabolism WP4971,0.9318789339276868,0.5261320402834763,0.0371198634026812,"['PLCB4', 'PIK3CA', 'PLCB1', 'SBF2']",0.9964075375310776,0,0,4
513,Differentiation Pathway WP2848,0.9322541195417356,0.4386134923592993,0.030768666753470904,"['TF', 'TGFB1']",0.9964075375310776,0,0,2
514,Monoamine GPCRs WP58,0.9322541195417356,0.4386134923592993,0.030768666753470904,"['HTR4', 'HTR5A']",0.9964075375310776,0,0,2
515,Osteoblast differentiation WP4787,0.9355708766810703,0.6453347045624532,0.04297824118109813,"['MAPK10', 'PIK3CA', 'STAT1', 'PRKCE', 'PRKCA', 'PPARG', 'PRKD1', 'MAPK6', 'RUNX2', 'FGFR2', 'GLI3']",0.9964075375310776,0,0,11
516,Wnt signaling WP428,0.9429462932338589,0.6339408731252214,0.037241459509435075,"['PPP3CA', 'SFRP1', 'JUN', 'CAMK2D', 'CCND2', 'PLCB4', 'PRKCA', 'ROR1', 'RAC1', 'PRICKLE1', 'PLCB1']",0.9964075375310776,0,0,11
517,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9454929541193501,0.41115355944837867,0.02304468127235211,"['MDH2', 'IDH3B']",0.9964075375310776,0,0,2
518,Tryptophan metabolism WP465,0.9454929541193501,0.41115355944837867,0.02304468127235211,"['ECHS1', 'WARS']",0.9964075375310776,0,0,2
519,Vitamin D in inflammatory diseases WP4482,0.9454929541193501,0.41115355944837867,0.02304468127235211,"['PPP3CA', 'NFKB1']",0.9964075375310776,0,0,2
520,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.9459952360006935,0.3290238450074516,0.0182666622165744,['MADD'],0.9964075375310776,0,0,1
521,Leptin Insulin Overlap WP3935,0.9459952360006935,0.3290238450074516,0.0182666622165744,['LEPR'],0.9964075375310776,0,0,1
522,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.9459952360006935,0.3290238450074516,0.0182666622165744,['NFKB1'],0.9964075375310776,0,0,1
523,NOTCH1 regulation of endothelial cell calcification WP3413,0.9459952360006935,0.3290238450074516,0.0182666622165744,['SOX6'],0.9964075375310776,0,0,1
524,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.9459952360006935,0.3290238450074516,0.0182666622165744,['TCF4'],0.9964075375310776,0,0,1
525,Riboflavin and CoQ disorders WP5037,0.9459952360006935,0.3290238450074516,0.0182666622165744,['PDSS2'],0.9964075375310776,0,0,1
526,T-cell receptor (TCR) signaling pathway WP69,0.9464347492123356,0.6034593209481102,0.033222396700884935,"['CDC42', 'MAP2K1', 'JUN', 'TGFB1', 'ITPR1', 'FYN', 'GAB2', 'HRAS', 'NFKB1']",0.9964075375310776,0,0,9
527,Glycerophospholipid Biosynthetic Pathway WP2533,0.9523026769170563,0.4483933292658125,0.021914038767553486,"['PIK3CA', 'CDIPT', 'CDS2']",0.9964075375310776,0,0,3
528,Wnt Signaling Pathway WP363,0.9558972768320789,0.5329136527344814,0.0240369758297801,"['CDK6', 'PRKCA', 'PPARG', 'ROR1', 'TCF4', 'RAC1']",0.9964075375310776,0,0,6
529,EPO Receptor Signaling WP581,0.9562424393635331,0.3869242068799193,0.017312459490529244,"['MAP2K1', 'STAT1']",0.9964075375310776,0,0,2
530,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.958587319365105,0.29907871562118954,0.012649420815715828,['ACOX1'],0.9964075375310776,0,0,1
531,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.958587319365105,0.29907871562118954,0.012649420815715828,['ACSL3'],0.9964075375310776,0,0,1
532,Type II diabetes mellitus WP1584,0.958587319365105,0.29907871562118954,0.012649420815715828,['PHKA2'],0.9964075375310776,0,0,1
533,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9599006202465737,0.46960089518836257,0.01921866104188929,"['HSP90AA1', 'JUN', 'BAX', 'MAP3K5']",0.9964075375310776,0,0,4
534,Breast cancer pathway WP4262,0.9622383167386602,0.6295523199458415,0.02423343834851609,"['NCOA1', 'MAP2K1', 'JUN', 'GADD45A', 'CETN3', 'BRAF', 'IGF1R', 'CDK6', 'PIK3CA', 'RPS6KB1', 'AKT3', 'BAX', 'HRAS', 'SKP1']",0.9964075375310776,0,0,14
535,Heart Development WP1591,0.9682440744910721,0.27412444113263784,0.008846291884602587,['MEF2C'],0.9964075375310776,0,0,1
536,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9720418670290001,0.46940298507462686,0.013310579920432945,"['RPTOR', 'MAP1LC3A', 'GTPBP2', 'ACACA', 'FTL']",0.9964075375310776,0,0,5
537,Complement and Coagulation Cascades WP558,0.9756495542259686,0.25300928579617105,0.006237139457993452,['CLTC'],0.9964075375310776,0,0,1
538,Purinergic signaling WP4900,0.9756495542259686,0.25300928579617105,0.006237139457993452,['P2RY14'],0.9964075375310776,0,0,1
539,Modulators of TCR signaling and T cell activation WP5072,0.9765001519956488,0.45631218905472637,0.010851274065602304,"['CDKN1B', 'NDUFB10', 'ELOB', 'MEF2D', 'NFKB1']",0.9964075375310776,0,0,5
540,Ethanol effects on histone modifications WP3996,0.9776214314288717,0.32877376071561687,0.0074410603534704085,"['KAT2B', 'AHCY']",0.9964075375310776,0,0,2
541,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9776447454371173,0.4997645874598175,0.011299138032216029,"['CDK8', 'SFRP1', 'JUN', 'CCND2', 'CDK6', 'HNRNPK', 'ROR1']",0.9964075375310776,0,0,7
542,Canonical and non-canonical Notch signaling WP3845,0.9813284446488939,0.23491058122205663,0.004427610958717528,['MFAP1'],0.9964075375310776,0,0,1
543,Gastric Cancer Network 1 WP2361,0.9813284446488939,0.23491058122205663,0.004427610958717528,['MCM4'],0.9964075375310776,0,0,1
544,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.9813284446488939,0.23491058122205663,0.004427610958717528,['RBBP4'],0.9964075375310776,0,0,1
545,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9813284446488939,0.23491058122205663,0.004427610958717528,['PPARA'],0.9964075375310776,0,0,1
546,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9813284446488939,0.23491058122205663,0.004427610958717528,['PDHA1'],0.9964075375310776,0,0,1
547,Vitamin A and carotenoid metabolism WP716,0.9813284446488939,0.23491058122205663,0.004427610958717528,['SULT1A1'],0.9964075375310776,0,0,1
548,Genes related to primary cilium development (based on CRISPR) WP4536,0.9840495589708645,0.5740078622238862,0.009229482972908409,"['DYNC2H1', 'IFT172', 'FBF1', 'WDR19', 'TXNDC15', 'DYNC2LI1', 'KIF3B', 'WDR60', 'TCTN3', 'TTC21B', 'SASS6', 'BBS9', 'KIFAP3', 'BBS4']",0.9964075375310776,0,0,14
549,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9856831827770121,0.21922503725782413,0.003161288975206445,['BAX'],0.9964075375310776,0,0,1
550,Notch Signaling WP268,0.985761341213795,0.35206935123042504,0.005049026963209237,"['KAT2B', 'NUMBL', 'NUMB']",0.9964075375310776,0,0,3
551,DNA IR-damage and cellular response via ATR WP4016,0.9865876212905512,0.48628232266633464,0.0065663368714320176,"['UPF1', 'MSH2', 'XRCC5', 'RBBP8', 'USP1', 'RPA2', 'PPM1D', 'MCPH1']",0.9964075375310776,0,0,8
552,NAD+ biosynthetic pathways WP3645,0.9890224316425152,0.20550018628912073,0.0022683658182855136,['QPRT'],0.9964075375310776,0,0,1
553,Fatty acid beta-oxidation WP143,0.9910447694857186,0.27385389489377565,0.0024634717723519477,"['ECHS1', 'ACSL3']",0.9964075375310776,0,0,2
554,16p11.2 distal deletion syndrome WP4950,0.9915829248783372,0.1933900236696765,0.0016346676088355944,['CD81'],0.9964075375310776,0,0,1
555,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9915829248783372,0.1933900236696765,0.0016346676088355944,['MAP1LC3A'],0.9964075375310776,0,0,1
556,Wnt signaling in kidney disease WP4150,0.9915829248783372,0.1933900236696765,0.0016346676088355944,['MAPK10'],0.9964075375310776,0,0,1
557,Glycerolipids and Glycerophospholipids WP4722,0.9935462240580732,0.182625434674615,0.00118244336644505,['CDIPT'],0.9964075375310776,0,0,1
558,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9935462240580732,0.182625434674615,0.00118244336644505,['EP300'],0.9964075375310776,0,0,1
559,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9935462240580732,0.182625434674615,0.00118244336644505,['RUNX1T1'],0.9964075375310776,0,0,1
560,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9960055913159983,0.32827303245057815,0.00131388249381274,"['SFRP1', 'JUN', 'CCND2', 'ROR1']",0.9964075375310776,0,0,4
561,Nanoparticle triggered autophagic cell death WP2509,0.99620575874965,0.16432563338301043,0.0006246769350123312,['MAP1LC3A'],0.9964075375310776,0,0,1
562,Ectoderm Differentiation WP2858,0.9964075375310776,0.5039887106528814,0.0018138205231020533,"['NLGN1', 'CTNND2', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'SOX2', 'PLCXD3', 'ARHGEF9', 'DMD', 'FYN', 'FGFR2', 'ANKS1B', 'ASTN1']",0.9964075375310776,0,0,14
